{"title":"Peptide Therapy","description":"\u003cp\u003eDiscover our curated peptide collection, a targeted line of advanced formulations designed to support vitality, recovery and radiant skin.\u003c\/p\u003e\n\u003cp\u003eKey Benefits:\u003c\/p\u003e\n\u003cp\u003e1. Rapid injury healing: Peptides are used in sports medicine to accelerate repair of tendons, ligaments and muscle tissue, shortening recovery time after injury.\u003c\/p\u003e\n\u003cp\u003e2. Skin Rejuvenation, Regeneration and Anti-aging: Copper peptides (GHK‑CU) and signaling peptides like Matrixyl stimulate collagen and elastin production which repair and rejuvenates skin, improves firmness and reduce the appearance of wrinkles.\u003c\/p\u003e\n\u003cp\u003e3. Weight Loss and Metabolic Support: Peptides help regulate appetite and support weight-management efforts.\u003c\/p\u003e\n\u003cp\u003e4. Cellular Communication and Remodeling: Peptides act as cellular messengers, directing processes like elastin synthesis, muscle relaxation for smoother facial contours and enhanced tissue growth and repair.\u003c\/p\u003e\n\u003cp\u003e5. Brain Health: Specific peptides can support better sleep cycles and improved focus, contributing to sharper cognition and mental clarity.\u003c\/p\u003e\n\u003cp\u003e6. Sexual Performance and Fertility: Specific peptides are used in human reproductive therapies for infertility and in areas related to sexual desire in both men and women. They are also used in  treatment of sex steroid-dependent cancers. Beyond reproduction, it influences brain regions involved in emotion, mood and anxiety and may have roles in cardiac metabolism. \u003c\/p\u003e","products":[{"product_id":"weight-loss-management-1-reta-1","title":"WeightLoss Management 1 (RT)","description":"\u003cp\u003eEffective weight management with Reta\u003cbr\u003ePackaging: \u003cbr\u003e((1) 5Vials (99% Purity)+ 5x7ml Vial of Bacteriostatic Water  Boxed (Brand Packaging)\u003c\/p\u003e\n\u003cp\u003e(2) 10Vials (99% Purity)+ 10x7ml Vial of Bacteriostatic Water Boxed (Brand Packaging)\u003c\/p\u003e\n\u003cp\u003eRetatrutide — Lyophilized Vial\u003c\/p\u003e\n\u003cp\u003eRetatrutide is a multi‑receptor agonist designed to engage incretin and related receptors that regulate appetite, energy expenditure and glucose metabolism. By simultaneously modulating these pathways, it is intended to produce greater weight‑loss and metabolic benefits compared with single‑target agents.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003cbr\u003e- Research‑grade retatrutide with documented purity  \u003cbr\u003e- Investigational activity on metabolic pathways relevant to weight management and glycemic control  \u003cbr\u003e- Shows potential to reduce body weight and improve metabolic parameters in experimental settings  \u003cbr\u003e- May support research into regenerative metabolic therapies and anti‑aging metabolic optimization  \u003cbr\u003e- Supplied as lyophilized vial(s) for reconstitution in laboratory environments\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product name: Retatrutide (investigational metabolic peptide)  \u003cbr\u003e- Category: Metabolic \/ investigational peptide (research)  \u003cbr\u003e- Format: Lyophilized powder in sterile vial (specified mg per vial to be set by supplier)  \u003cbr\u003e- Typical administration (research): Subcutaneous injection per protocol  \u003cbr\u003e- Storage (reconstituted): Refrigerate at 2–8 °C; follow institutional SOPs for validated stability and avoid repeated freeze–thaw cycles\u003c\/p\u003e\n\u003cp\u003ePotential Research Applications\u003c\/p\u003e\n\u003cp\u003e- Preclinical and clinical‑stage metabolic research (weight‑loss, appetite regulation)  \u003cbr\u003e- Studies of glycemic control and insulin sensitivity  \u003cbr\u003e- Body‑composition and fat‑loss intervention research  \u003cbr\u003e- Investigations into metabolic drivers of aging and regenerative metabolic therapies  \u003cbr\u003e- Combination studies with exercise and dietary interventions\u003c\/p\u003e\n\u003cp\u003eReconstitution \u0026amp; Dosing Guide\u003c\/p\u003e\n\u003cp\u003eImportant: The following examples are for laboratory reference only. Confirm all calculations, aseptic technique and solvent compatibility with your institutional SOPs before use. Adjust volumes and concentrations according to the vial strength provided by your supplier.\u003c\/p\u003e\n\u003cp\u003eExample Reconstitution\u003c\/p\u003e\n\u003cp\u003eBelow are straightforward conversions and common dosing examples for a 60 mg vial reconstituted with 3.0 mL bacteriostatic water (resulting concentration: 60 mg ÷ 3.0 mL = 20 mg\/mL). Use only for informational\/research planning — verify calculations and follow institutional SOPs.\u003c\/p\u003e\n\u003cp\u003eConcentration\u003cbr\u003e- 20 mg\/mL (20,000 µg\/mL)\u003c\/p\u003e\n\u003cp\u003eVolume-to-dose conversions (mg → mL → U‑100 insulin units)\u003cbr\u003e- 0.4 mg = 0.02 mL = 2 units  \u003cbr\u003e- 0.8 mg = 0.04 mL = 4 units  \u003cbr\u003e- 1.2 mg = 0.06 mL = 6 units  \u003cbr\u003e- 1.6 mg = 0.08 mL = 8 units  \u003cbr\u003e- 2.0 mg = 0.10 mL = 10 units\u003c\/p\u003e\n\u003cp\u003eRange and Frequency\u003c\/p\u003e\n\u003cp\u003eStarting \/ low exploratory dose: approximately 0.4 mg (400 µg) once daily\u003cbr\u003eTypical escalation steps: 0.4 → 0.8 → 1.2 → 1.6 → 2.0 → 2.4 mg (increments and cadence depend on protocol)\u003cbr\u003eDosing frequency in studies: once daily subcutaneous injection\u003c\/p\u003e\n\u003cp\u003eTypical Titration Approach in Trials\u003c\/p\u003e\n\u003cp\u003eUse a conservative starting dose (e.g., 0.4 mg\/day) and predefined titration steps in your protocol.\u003cbr\u003eAllow 1–4 weeks between dose escalations to assess tolerability; length depends on the expected side‑effect profile and study design.\u003cbr\u003eDefine stopping rules for adverse events and criteria for dose reduction.\u003cbr\u003eMonitor weight, appetite, GI symptoms, blood glucose, and any other protocol‑specified biomarkers.\u003c\/p\u003e\n\u003cp\u003eCycle Length and Duration\u003c\/p\u003e\n\u003cp\u003eTreatment periods in trials commonly range from 12 weeks up to 48 weeks depending on endpoints; early‑phase dose‑finding cohorts often use 4–12 week blocks per dose level.\u003cbr\u003eThere is typically no short “on\/off” cycling; continuous daily dosing is the norm while titrating.\u003c\/p\u003e\n\u003cp\u003eSafety \/ Tolerability Notes\u003cbr\u003e- Beneficial effects: reduced appetite, weight loss, improved glycemic markers and insulin sensitivity and changes in energy expenditure.  \u003cbr\u003e- Possible adverse events: gastrointestinal symptoms, transient headache, injection‑site reactions and glycemic changes. Monitor for hypoglycemia if combined with other glucose‑lowering agents.  \u003cbr\u003e- Document and monitor all adverse events according to institutional safety procedures.\u003c\/p\u003e\n\u003cp\u003eAdministration Notes\u003cbr\u003e- Subcutaneous injection is the typical route in research protocols; timing (morning vs evening), frequency, and titration depend on study aims and safety data.  \u003cbr\u003e- Consider gradual dose escalation protocols to monitor tolerability and metabolic responses.  \u003c\/p\u003e\n\u003cp\u003eCycle Length and Scheduling\u003cbr\u003e- Cycle lengths vary by study design; many metabolic peptide studies use daily or weekly dosing schedules depending on pharmacokinetics.  \u003cbr\u003e- Tapering may not be required but should be defined in the protocol to minimize rebound effects.\u003c\/p\u003e\n\u003cp\u003eHandling, Stability and Storage After Reconstitution\u003cbr\u003e- Reconstituted solutions: refrigerate (2–8 °C)\u003cbr\u003e- Use aseptic technique, sterile syringes and needles for preparation and dosing.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003cbr\u003eQ: What dose should be used?  \u003cbr\u003eA: Dose selection must be based on supplier potency data, preclinical pharmacology, and an approved study protocol. Begin with conservative doses and escalate carefully under monitoring.\u003c\/p\u003e\n\u003cp\u003eQ: How is retatrutide administered?  \u003cbr\u003eA: Subcutaneous injection is standard in research; alternative routes depend on formulation and experimental design.\u003c\/p\u003e\n\u003cp\u003eQ: Can it be combined with other metabolic agents?  \u003cbr\u003eA: Combination studies are common but require careful monitoring for additive effects on glucose and other systems.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003cbr\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"text-decoration: underline;\"\u003eFor this price, there is a need to pre-order, waiting time 5 to 7 days.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"RT20 Pep 5V+5B","offer_id":52047875047713,"sku":null,"price":600.0,"currency_code":"USD","in_stock":true},{"title":"RT20 Pep 10V+10B","offer_id":52047875080481,"sku":null,"price":1100.0,"currency_code":"USD","in_stock":true},{"title":"RT40 Pep 5V+5B","offer_id":52047875113249,"sku":null,"price":850.0,"currency_code":"USD","in_stock":true},{"title":"RT40 Pep 10V+10B","offer_id":52047875146017,"sku":null,"price":1300.0,"currency_code":"USD","in_stock":true},{"title":"RT60 Pep 5V+5B","offer_id":52047875178785,"sku":null,"price":1050.0,"currency_code":"USD","in_stock":true},{"title":"RT60 Pep 10V+10B","offer_id":52047875211553,"sku":null,"price":1900.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/wlm1reta.jpg?v=1764308054"},{"product_id":"weightloss-management-2-trz","title":"Weight Loss Management 2 (TRZ)","description":"\u003cp\u003eWeight Management Potential with Tirz\u003cbr\u003e\u003cbr\u003ePackaging:\u003cbr\u003e(1) 5Vials (99% Purity)+ 5x7ml Vial of Bacteriostatic Water, Boxed (Brand Packaging)\u003c\/p\u003e\n\u003cp\u003e(2) 10Vials (99% Purity)+ 10x7ml Vial of Bacteriostatic Water Boxed (Brand Packaging)\u003c\/p\u003e\n\u003cp\u003eTirzepatide is a unimolecular dual agonist that activates both GIP and GLP‑1 receptors, producing combined incretin effects: enhanced glucose‑dependent insulin secretion, reduced glucagon secretion, delayed gastric emptying, and appetite suppression. These combined actions contribute to improved glycemic control and significant reductions in body weight observed in clinical research.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research‑grade tirzepatide with documented purity  \u003cbr\u003e- Dual GIP\/GLP‑1 receptor agonist activity relevant to glucose regulation and appetite suppression  \u003cbr\u003e- Demonstrates substantial body‑weight reduction and improved metabolic markers in clinical research settings  \u003cbr\u003e- Supports studies on insulin sensitivity, energy balance and obesity\/metabolic disease interventions  \u003cbr\u003e- Supplied as lyophilized vial(s) for laboratory reconstitution and controlled use\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003cbr\u003e- Product name: Tirzepatide (investigational dual‑agonist peptide)  \u003cbr\u003e- Category: Metabolic \/ incretin‑class research peptide  \u003cbr\u003e- Format: Lyophilized powder in sterile vial (specified mg per vial to be set by supplier)  \u003cbr\u003e- Typical administration (research): Subcutaneous injection per protocol  \u003cbr\u003e- Storage (reconstituted): Refrigerate at 2–8 °C\u003c\/p\u003e\n\u003cp\u003ePotential Research Applications\u003cbr\u003e- Clinical and preclinical studies of type 2 diabetes and glycemic control  \u003cbr\u003e- Obesity and body‑composition research (weight‑loss mechanisms)  \u003cbr\u003e- Studies on appetite regulation, energy expenditure and metabolic biomarkers  \u003cbr\u003e- Combination interventions with diet, exercise or other metabolic agents\u003c\/p\u003e\n\u003cp\u003eReconstitution \u0026amp; Dosing Guide\u003cbr\u003eImportant: The following examples are for laboratory reference only. Confirm all calculations, aseptic technique and solvent compatibility with your institutional SOPs and supplier instructions before use.\u003c\/p\u003e\n\u003cp\u003eExample Reconstitution\u003cbr\u003eBelow are straightforward conversions and common dosing examples for a 60 mg vial reconstituted with 3.0 mL bacteriostatic water (resulting concentration: 60 mg ÷ 3.0 mL = 20 mg\/mL).\u003c\/p\u003e\n\u003cp\u003eConcentration\u003cbr\u003e- 20 mg\/mL (20,000 µg\/mL)\u003c\/p\u003e\n\u003cp\u003eVolume-to-dose conversions (mg → mL → U‑100 insulin units)\u003cbr\u003e- 0.5 mg = 0.025 mL = 2.5 units  \u003cbr\u003e- 1.0 mg = 0.05 mL = 5 units  \u003cbr\u003e- 1.5 mg = 0.075 mL = 7.5 units  \u003cbr\u003e- 2.0 mg = 0.10 mL = 10 units  \u003cbr\u003e- 2.5 mg = 0.125 mL = 12.5 units  \u003cbr\u003e- 5.0 mg = 0.25 mL = 25 units  \u003cbr\u003e- 10.0 mg = 0.50 mL = 50 units\u003c\/p\u003e\n\u003cp\u003eInsulin‑syringe conversion (U‑100 reference; 100 units = 1.0 mL)\u003cbr\u003e- After you define vial concentration (mg\/mL), convert mg → mL → insulin units for subcutaneous delivery. Example at 5 mg\/mL concentration: 1.0 mg = 0.20 mL = 20 units. Always calculate from the actual vial concentration.\u003c\/p\u003e\n\u003cp\u003eCommon Research Dosing Examples\u003c\/p\u003e\n\u003cp\u003e- Typical mg-range single doses used in some protocols: 1 mg, 2 mg, 5 mg or 10 mg per administration (see conversions above).  \u003cbr\u003e- Weekly clinical-style dosing (if modelling agents dosed weekly): e.g., 2.5 mg, 5 mg, 10 mg once weekly — volumes 0.125 mL, 0.25 mL, 0.50 mL respectively.\u003cbr\u003e- Fixed weekly subcutaneous dosing is typical in clinical programs (e.g., once weekly injections). Clinical study dose levels have included incremental doses up to several milligrams per week (protocol dependent).  \u003cbr\u003e- Typical studied dose escalation sequence in trials (example reference pattern): 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg (once weekly), with each step maintained for several weeks before escalation to improve tolerability. Exact steps and durations depend on protocol.\u003c\/p\u003e\n\u003cp\u003eAdministration Notes\u003c\/p\u003e\n\u003cp\u003e- Subcutaneous injection is the commonly used route in clinical and research settings. Tirzepatide is typically administered once weekly in clinical trials; dosing frequency should be defined by your study protocol.  \u003cbr\u003e- Titration schedules are widely used to mitigate gastrointestinal side effects: start at a low weekly dose and escalate per protocol.  \u003cbr\u003e- Monitor blood glucose, body weight, gastrointestinal symptoms and other safety markers per protocol.\u003c\/p\u003e\n\u003cp\u003eCycle Length and Scheduling\u003c\/p\u003e\n\u003cp\u003e- Clinical trials generally use continuous weekly dosing over months; dose‑finding studies escalate over several weeks to reach target maintenance doses.  \u003cbr\u003e- Tapering is not typically required when discontinuing after short‑term research use, but follow protocol‑specified discontinuation procedures to monitor for metabolic rebound.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events\u003cbr\u003e- Expected observations: improved glycemic control, reduced appetite, and clinically significant weight loss over weeks to months when combined with lifestyle interventions.  \u003cbr\u003e- Common class‑related adverse events: gastrointestinal symptoms, decreased appetite, and injection‑site reactions. Monitor for hypoglycemia especially when used with other glucose‑lowering agents.  \u003cbr\u003e- Record and manage adverse events according to institutional safety procedures.\u003c\/p\u003e\n\u003cp\u003eHandling, Stability and Storage After Reconstitution\u003cbr\u003e- Reconstituted solutions: refrigerate at 2–8 °C\u003cbr\u003e- Use aseptic technique and sterile supplies for reconstitution and dosing.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003cbr\u003eQ: How is tirzepatide typically dosed in studies?  \u003cbr\u003eA: In clinical trials, tirzepatide is commonly administered once weekly with stepwise escalation (example: 2.5 mg up‑titration to higher maintenance doses) to manage tolerability.\u003c\/p\u003e\n\u003cp\u003eQ: What effects are typically observed?  \u003cbr\u003eA: Improved glycemic markers and substantial body‑weight reductions are commonly reported in clinical research; response magnitude varies by dose and study duration.\u003c\/p\u003e\n\u003cp\u003eQ: Are there safety concerns?  \u003cbr\u003eA: Gastrointestinal adverse effects are the most frequent; hypoglycemia risk increases when combined with other glucose‑lowering therapies. Monitor per protocol.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003cbr\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"font-size: 0.875rem;\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003eFor this price, there is a need to pre-order, waiting time 5 to 7 days.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"TRZ20 Pep 5V+5B","offer_id":52047936061729,"sku":null,"price":450.0,"currency_code":"USD","in_stock":true},{"title":"TRZ20 Pep 10V+10B","offer_id":52047936094497,"sku":null,"price":800.0,"currency_code":"USD","in_stock":true},{"title":"TRZ40 Pep 5V+5B","offer_id":52047936127265,"sku":null,"price":700.0,"currency_code":"USD","in_stock":true},{"title":"TRZ40 Pep 10V+10B","offer_id":52047936160033,"sku":null,"price":1000.0,"currency_code":"USD","in_stock":true},{"title":"TRZ60 Pep 5v+5B","offer_id":52047936192801,"sku":null,"price":850.0,"currency_code":"USD","in_stock":true},{"title":"TRZ60 Pep 10V+10B","offer_id":52047936225569,"sku":null,"price":1550.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/wlm1tirz.jpg?v=1764311879"},{"product_id":"glow-solution","title":"GHK CU Glow Solution","description":"\u003cp\u003eGHK-CU is a research‑grade copper‑binding tripeptide supplied as a lyophilized powder for investigator‑controlled reconstitution. Widely used in preclinical and laboratory studies, GHK-CU supports collagen synthesis, tissue remodeling, wound healing and hair growth.\u003c\/p\u003e\n\u003cp\u003eUnlock the secret to youthful, luminous skin with the Glow Pen, expertly infused with GHK-CU (glycyl-L-histidyl-L-lysine copper) peptide injections. This groundbreaking product harnesses the incredible anti-aging, regenerative, and healing properties of GHK-CU to provide a transformative skincare experience tailored just for you.\u003c\/p\u003e\n\u003cp\u003eKey Benefits\u003c\/p\u003e\n\u003cp\u003e- Skin Rejuvenation and Anti-Aging:\u003cbr\u003eExperience the power of GHK-CU as it stimulates collagen and elastin production, resulting in firmer, thicker, and more elastic skin. Wave goodbye to fine lines and wrinkles while enhancing your skin’s overall texture!\u003c\/p\u003e\n\u003cp\u003e- Skin Brightening and Lightening:\u003cbr\u003eGHK-CU subtly brightens skin by promoting rejuvenation and enhancing skin tone. While not primarily a lightening agent, it helps reduce discoloration and promotes a uniform complexion. Regular use may diminish hyperpigmentation and melasma, yielding a radiant and luminous appearance over time.\u003c\/p\u003e\n\u003cp\u003e- Accelerated Wound Healing:\u003cbr\u003eKnown for its superior ability to enhance tissue repair and minimize scar formation, the Glow Pen is highly effective for post-surgical recovery and healing from various skin injuries.\u003c\/p\u003e\n\u003cp\u003e- Hair Growth and Density:\u003cbr\u003eBoost blood flow to the scalp and increase follicle size, encouraging thicker, healthier hair while combating hair loss.\u003c\/p\u003e\n\u003cp\u003e- Reduced Inflammation and Oxidative Stress:\u003cbr\u003eActs as a powerful anti-inflammatory and antioxidant, protecting cells from damage and slowing the aging process.\u003c\/p\u003e\n\u003cp\u003e- Tissue Repair and Regeneration:\u003cbr\u003eReverses age-related skin thinning, repairs protective skin barriers, and improves tone by addressing photodamage.\u003c\/p\u003e\n\u003cp\u003e- Potential Systemic Health Benefits:\u003cbr\u003eEmerging research suggests that GHK-CU may also play a role in treating chronic obstructive pulmonary disease (COPD), reducing neurodegeneration, and supporting recovery from strokes or heart attacks.\u003c\/p\u003e\n\u003cp\u003eAchieve Visible Results\u003c\/p\u003e\n\u003cp\u003eWith consistent use of the Glow Pen, noticeable improvements can begin within just 2 to 4 weeks. You may observe enhanced skin hydration and texture, while more significant changes, such as diminished fine lines, improved elasticity, and a brighter complexion, can manifest within 4 to 12 weeks. Optimal rejuvenation—such as increased firmness and reduced deeper wrinkles—typically requires 3 to 6 months.\u003c\/p\u003e\n\u003cp\u003eProduct Variants\u003c\/p\u003e\n\u003cp\u003e- Pen (100mg):\u003cbr\u003eEasy to store, the pen reduces contamination risks and provides a precise dosing mechanism. \u003c\/p\u003e\n\u003cp\u003e- Vial (100mg):Requires careful handling and discipline. Store it in a dedicated container before refrigeration to minimize contamination risks. Always use a new needle and syringe for extraction. Supplied in 100mg + 1 vial of bacteriostatic water (3ml).\u003c\/p\u003e\n\u003cp\u003eReconstitution Guide\u003c\/p\u003e\n\u003cp\u003eImportant: The following reconstitution examples are for research reference only. Validate calculations, aseptic technique and solvent compatibility with your laboratory SOPs prior to use.\u003c\/p\u003e\n\u003cp\u003e100 mg vial example (100 mg + 3 mL bacteriostatic water)\u003cbr\u003e- Resulting concentration: 33.4 mg\/mL (same concentration as above)\u003cbr\u003e- Adjust volumes proportionally for target doses\u003cbr\u003e- Example dosing volumes (U‑100 insulin syringe reference):\u003cbr\u003e  - 2 mg = 0.06 mL (6 units on the dial tip if you are using an EZpen)\u003cbr\u003e  - 4 mg = 0.12 mL (12 units on the dial tip if you are using an EZpen)\u003cbr\u003e  - 5 mg = 0.15 mL (15 units on the dial tip if you are using an EZpen)\u003c\/p\u003e\n\u003cp\u003eAn EZpen is easier to use and is reusable and refillable. There are YouTube tutorials which teaches how to fill and load a cartridge into an easy pen after reconstituting the peptide.\u003c\/p\u003e\n\u003cp\u003eDosage Recommendations\u003c\/p\u003e\n\u003cp\u003eFor Anti-Aging and Hair Growth: Administer 1mg to a maximum of 5mg per shot, once a week. Monitor for potential side effects like nausea and adjust dosage as needed.\u003cbr\u003eFor Skin Brightening and Improvement: Administer 1mg to 2mg per shot, once a week. Again, monitor for nausea and adjust as necessary.\u003c\/p\u003e\n\u003cp\u003ePossible Observations\u003c\/p\u003e\n\u003cp\u003e- Local injection site mild irritation\u003cbr\u003e- Mild topical irritation when used in concentrated formulations (rare)\u003cbr\u003e- No major systemic adverse events widely reported in preclinical literature, but copper handling and accumulation should be considered in long‑term studies\u003c\/p\u003e\n\u003cp\u003eStorage, Stability and Handling After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Reconstituted solutions: refrigerate at 2–8 °C\u003cbr\u003e- Minimize freeze–thaw cycles; use sterile technique when handling\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003cbr\u003eQ: Is 1 mg a suitable starting research dose?\u003cbr\u003eA: Many preclinical protocols reference 1 mg as a conservative starting point; optimal dosing depends on model, route and endpoints.\u003c\/p\u003e\n\u003cp\u003eQ: Should GHK-CU be cycled?\u003cbr\u003eA: Many investigators use 5 days on \/ 2 days off schedules to limit theoretical copper build‑up and maintain cost efficiency; final schedule should be study‑specific.\u003c\/p\u003e\n\u003cp\u003eQ: Can it be used topically?\u003cbr\u003eA: Yes—GHK-CU is commonly formulated into topical preparations for skin studies; ensure formulation stability and test for irritation in pilot assays.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003cbr\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Pen 100mg (Pharm Labeled and supplied in a box)","offer_id":52324717494561,"sku":null,"price":220.0,"currency_code":"USD","in_stock":true},{"title":"GHK-CU Vial 100mg (+ 3ml Bac Water) (Only Vial, No Pen and No Box)","offer_id":52324717527329,"sku":null,"price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/GlowSolution-MoonspellsBeauty1.jpg?v=1775453092"},{"product_id":"klow80-regenerative-peptide-blend-nbsp","title":"KLOW80 Regenerative Blend","description":"\u003cp\u003eKLOW80 is a multi‑peptide formulation combining 80 mg in total of 50 mg GHK‑Cu + 10 mg BPC‑157 + 10 mg TB‑500 + 10 mg KPV in a single lyophilized vial. This synergistic blend is formulated to support collagen synthesis, accelerate tissue repair, reduce inflammation and promote gut and musculoskeletal recovery in preclinical and laboratory studies.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Four‑component regenerative peptide blend (GHK‑Cu + BPC‑157 + TB‑500 + KPV)\u003cbr\u003e- Designed to enhance collagen production, angiogenesis, actin‑mediated tissue repair and anti‑inflammatory responses\u003cbr\u003e- Supports skin repair, tendon\/ligament healing, muscle regeneration and gut integrity\u003cbr\u003e- Supplied lyophilized to allow controlled reconstitution and dosing\u003cbr\u003e- Ideal for regenerative medicine, musculoskeletal and anti‑aging.\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product name: KLOW80 (peptide blend) (Purity: 99+% HPLC)\u003cbr\u003e- Composition per vial (80 mg): GHK‑Cu 50mg + BPC‑157 10mg + TB‑500 10mg + KPV 10mg\u003cbr\u003e- Category: Regenerative peptide blend\u003cbr\u003e- Supplied as: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3 ml bac water\u003c\/strong\u003e\u003c\/em\u003e\u003cbr\u003e- Administration (research\/preclinical): Subcutaneous injection (typical)\u003cbr\u003e- Storage (reconstituted): Keep at 2–8 °C\u003c\/p\u003e\n\u003cp\u003eMechanism of Action (Research Summary)\u003c\/p\u003e\n\u003cp\u003e- GHK‑Cu: copper‑binding tripeptide that stimulates collagen synthesis and extracellular matrix remodeling.\u003cbr\u003e- BPC‑157: peptide reported to promote angiogenesis and support tissue healing and gut integrity.\u003cbr\u003e- TB‑500 (Thymosin β‑4 fragment): facilitates actin polymerization and cellular migration for repair processes.\u003cbr\u003e- KPV: short anti‑inflammatory peptide that can modulate pro‑inflammatory cytokine activity.\u003c\/p\u003e\n\u003cp\u003eCombined, these components target complementary pathways involved in tissue repair, remodeling and inflammation reduction.\u003c\/p\u003e\n\u003cp\u003ePotential Research Applications\u003c\/p\u003e\n\u003cp\u003e- Dermal wound healing and skin regeneration studies\u003cbr\u003e- Tendon, ligament and muscle repair in musculoskeletal models\u003cbr\u003e- Anti‑inflammatory and gut integrity research\u003cbr\u003e- Regenerative medicine and anti‑aging investigations\u003cbr\u003e- Combination protocols with physiotherapy, biomaterials or adjunctive therapeutics\u003c\/p\u003e\n\u003cp\u003eReconstitution and Dosing Guide\u003cbr\u003eImportant: The following examples are for laboratory reference only. Confirm calculations, aseptic technique and solvent compatibility with your institutional protocols before use.\u003c\/p\u003e\n\u003cp\u003eExample reconstitution (80 mg vial + 3.0 mL bacteriostatic water)\u003cbr\u003e- Approximate concentration: 26.7 mg total peptide per mL\u003cbr\u003e- Example dosing volumes (U‑100 insulin syringe reference):\u003cbr\u003e  - 3 mg total = 0.11 mL (≈11 units)\u003cbr\u003e  - 4 mg total = 0.15 mL (≈15 units)\u003c\/p\u003e\n\u003cp\u003eSuggested Research Protocol\u003c\/p\u003e\n\u003cp\u003e- Typical investigational dose: 3–4 mg total per administration (adjust per study design)\u003cbr\u003e- Frequency: once daily or 5 times per week\u003cbr\u003e- Cycle length examples: 4–8 weeks on with 2–8 weeks off\u003cbr\u003e- Tapering: generally not required for short cycles\u003cbr\u003e- Combine with rehabilitative interventions (exercise, physiotherapy) for synergistic effects\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003c\/p\u003e\n\u003cp\u003e- The blend pairs peptides that promote collagen production, angiogenesis, cellular migration and anti‑inflammatory signaling — a multi‑modal approach often used in regenerative research.\u003cbr\u003e- Reported experimental endpoints include accelerated wound closure, improved tendon\/ligament healing, reduced local inflammation and improved markers of tissue remodeling in controlled models.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events\u003cbr\u003e- Mild local injection site irritation (reported rarely)\u003cbr\u003e- Mild gastrointestinal discomfort if oral\/topical routes are explored (very rare)\u003cbr\u003e- No major systemic adverse events commonly reported in preclinical literature; however, individual components should be assessed for safety in the chosen model\u003c\/p\u003e\n\u003cp\u003eStorage, Stability and Handling After Reconstitution\u003cbr\u003e- Reconstituted solutions: keep at 2–8 °C and protect from light\u003cbr\u003e- Minimize freeze–thaw cycles and employ sterile technique throughout handling\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003cbr\u003e- Follow institutional biosafety, handling and waste disposal protocols.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003cbr\u003eQ: Is 3 mg a suitable starting research dose?\u003cbr\u003eA: 3 mg total is commonly used as an investigational starting point in combination protocols; dose selection should follow study design and institutional approval.\u003c\/p\u003e\n\u003cp\u003eQ: Can the blend be used long‑term?\u003cbr\u003eA: Cycling is often recommended to balance efficacy, cost and theoretical exposure; study‑specific guidance should be followed.\u003c\/p\u003e\n\u003cp\u003eQ: How soon might effects be observed?\u003cbr\u003eA: Tissue repair and anti‑inflammatory benefits may be measurable within weeks in controlled experimental models, depending on endpoints and concomitant therapies.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003cbr\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52540530032929,"sku":null,"price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/klow80_8fda254b-edec-421c-b458-8c447a1fcedb.jpg?v=1776744733"},{"product_id":"tesamorelin","title":"Tesamorelin Body Transformation","description":"\u003cp\u003eTesamorelin is a research‑grade synthetic analogue of growth hormone‑releasing hormone (GHRH) supplied as a lyophilized powder for investigator‑controlled reconstitution. It stimulates pituitary growth hormone secretion and is used in preclinical and laboratory studies investigating visceral fat reduction, metabolic effects and regenerative processes.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- GHRH analogue\u003cbr\u003e- Stimulates endogenous growth hormone release via GHRH receptor activation\u003cbr\u003e- Investigational tool for visceral fat reduction, metabolic health and muscle support\u003cbr\u003e- Supplied lyophilized to allow custom reconstitution and dosing\u003cbr\u003e- Available vial size: 10mg\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003cbr\u003e- Product name: Tesamorelin 10mg (Purity: 99+% HPLC)\u003cbr\u003e- Category: GHRH analogue \/ research peptide\u003cbr\u003e- Supplied in: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3ml bac water\u003c\/strong\u003e\u003c\/em\u003e\u003cbr\u003e- Administration (research\/preclinical): Subcutaneous injection (typical)\u003cbr\u003e- Storage (reconstituted): Store at 2–8 °C\u003c\/p\u003e\n\u003cp\u003ePotential Research Applications\u003cbr\u003e- Studies on visceral fat reduction and body composition\u003cbr\u003e- Investigations of GH‑mediated metabolic and anabolic effects\u003cbr\u003e- Preclinical research into aging biology and regenerative outcomes\u003cbr\u003e- Combination studies with exercise, nutrition or other metabolic interventions\u003c\/p\u003e\n\u003cp\u003eReconstitution \u0026amp; Dosing Guide\u003cbr\u003eImportant: The following examples are for laboratory reference only. Validate all calculations, aseptic technique and solvent compatibility with your institutional protocols before use.\u003c\/p\u003e\n\u003cp\u003eExample reconstitution (10 mg vial + 1.0 mL bacteriostatic water)\u003cbr\u003e- Resulting concentration: 10 mg\/mL\u003cbr\u003e- Example dosing volumes (U‑100 insulin syringe reference):\u003cbr\u003e  - 1.0 mg = 0.10 mL (10 units)\u003cbr\u003e  - 1.5 mg = 0.15 mL (15 units)\u003cbr\u003e  - 2.0 mg = 0.20 mL (20 units)\u003c\/p\u003e\n\u003cp\u003eSuggested Research Protocol\u003cbr\u003e- Typical investigational dose range reported in experimental contexts: 0.5–2.0 mg per administration\u003cbr\u003e- Common schedule used in research: once daily (Monday–Friday) to support GH release and metabolic endpoints\u003cbr\u003e- Cycle lengths seen in study designs: 8–16 weeks on with 4–8 weeks off; tapering generally not required\u003cbr\u003e- Protocols should be designed and approved by qualified investigators and institutional oversight\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003cbr\u003e- Tesamorelin has been investigated for its capacity to reduce visceral adipose tissue and improve aspects of metabolic health via increased pituitary GH release.\u003cbr\u003e- Effects are often reported within weeks when combined with dietary and exercise interventions; outcomes depend on model, dose and study design.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events (Preclinical\/Experimental Context)\u003cbr\u003e- Mild local injection site irritation\u003cbr\u003e- Temporary headache or dizziness (very rare)\u003c\/p\u003e\n\u003cp\u003eStorage, Stability and Handling After Reconstitution\u003cbr\u003e- Reconstituted solutions: store at 2–8 °C and protect from prolonged light exposure\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003cbr\u003e- Follow institutional biosafety, handling and waste disposal protocols.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003cbr\u003eQ: Is 0.5 mg a reasonable starting research dose?  \u003cbr\u003eA: Many protocols begin conservatively at 0.5–1.0 mg; dose selection should be guided by study objectives and approved by oversight bodies.\u003c\/p\u003e\n\u003cp\u003eQ: Can Tesamorelin be dosed daily?  \u003cbr\u003eA: Yes — daily dosing or 5 days a week (often Monday–Friday) is commonly used in experimental designs to support sustained GH release, but schedules should be study‑specific.\u003c\/p\u003e\n\u003cp\u003eQ: When might effects be seen?  \u003cbr\u003eA: Changes in visceral fat and body composition may be observable within weeks depending on the experimental model and concurrent interventions.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003cbr\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52540592390433,"sku":null,"price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/tesamorelin_6403fb3c-2874-46a0-ad2c-81102d2469da.jpg?v=1776744664"},{"product_id":"cjc1295-ipamorelin-youthful-vitality-blend","title":"CJC1295 + Ipamorelin Youthful Vitality Blend","description":"\u003cp\u003eA research‑grade peptide blend combining CJC‑1295 (No DAC) and Ipamorelin supplied as a lyophilized vial. This synergistic combination is formulated to stimulate pulsatile growth hormone release and is intended for laboratory and preclinical research into muscle recovery, fat metabolism, sleep and regenerative pathways.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research grade GHRH and ghrelin receptor agonist blend (99+% purity, third‑party tested)\u003cbr\u003e- Synergistic stimulation of endogenous growth hormone secretion\u003cbr\u003e- Supports preclinical studies of muscle growth, fat loss, recovery and anti‑aging biology\u003cbr\u003e- Supplied lyophilized for investigator‑controlled reconstitution and dosing\u003cbr\u003e- Available format: 5 mg total (5 mg CJC‑1295 + 5 mg Ipamorelin)\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product name: CJC‑1295 + Ipamorelin Blend (5 mg + 5 mg) (Purity: 99+% HPLC)\u003cbr\u003e- Growth hormone‑releasing peptide blend (research chemical)\u003cbr\u003e- Supplied in: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3ml bac water\u003c\/strong\u003e\u003c\/em\u003e\u003cbr\u003e- Administration (research\/preclinical): Subcutaneous injection preferred\u003cbr\u003e- Storage (reconstituted): Refrigerate at 2–8 °C\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003e- CJC‑1295 (No DAC) is a GHRH analogue that activates GHRH receptors to promote growth hormone release.\u003cbr\u003e- Ipamorelin is a selective growth hormone secretagogue acting via ghrelin receptors to amplify pulsatile GH secretion.\u003cbr\u003e- In combination, these peptides act synergistically to enhance endogenous GH pulsatility, supporting anabolic, lipolytic and regenerative processes in preclinical models.\u003c\/p\u003e\n\u003cp\u003ePotential Research Applications\u003cbr\u003e- Preclinical models of muscle mass, recovery and atrophy\u003cbr\u003e- Studies of fat loss and metabolic modulation mediated by GH signaling\u003cbr\u003e- Investigations on sleep, recovery and circadian GH dynamics\u003cbr\u003e- Regenerative and anti‑aging pathway research involving GH‑mediated mechanisms\u003cbr\u003e- Combination protocols with exercise or nutritional interventions\u003c\/p\u003e\n\u003cp\u003eReconstitution Guide\u003cbr\u003eImportant: The following are informational reference protocols only. Validate all calculations, aseptic technique and solvent compatibility with your institution’s protocols before use.\u003c\/p\u003e\n\u003cp\u003e(10 mg vial + 3 mL bacteriostatic water)\u003cbr\u003e- Example dosing volumes (U‑100 insulin syringe reference):\u003cbr\u003e  - 0.25 mg CJC‑1295 + 0.5mg Ipamorelin peptides (combined): 0.15 mL (15 units)\u003cbr\u003e  - 0.5 mg CJC‑1295 + 1mg Ipamorelin peptides: 0.30 mL (30 units)\u003c\/p\u003e\n\u003cp\u003eSuggested Research Dosing Parameters\u003cbr\u003e- Common investigational range for each peptide: 0.25–0.5 mg per dose (combined dosing shown above)\u003cbr\u003e- Typical administration timing used in research: Once daily, preferably before bedtime on an empty stomach to align with endogenous GH release\u003cbr\u003e- Common experimental schedule: 5 days on, 2 days off to maintain responsiveness and cost efficiency\u003cbr\u003e- Cycle lengths in some study designs: 8–12 weeks on with 4–8 weeks off; tapering generally not required\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003c\/p\u003e\n\u003cp\u003e- The blend is used to promote pulsatile GH secretion, which in turn may support muscle repair, fat reduction and improvements in recovery metrics in controlled preclinical studies.\u003cbr\u003e- Individual peptides have demonstrated activity in the 250–1000 mcg (0.25–1.0 mg) range in various investigative contexts; combined protocols aim to leverage complementary mechanisms.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events\u003cbr\u003e- Mild local injection site irritation (rare)\u003cbr\u003e- Temporary water retention or mild edema in some investigational reports\u003cbr\u003e- Mild headache (infrequent)\u003c\/p\u003e\n\u003cp\u003eStorage, Stability and Handling After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Reconstituted solutions: refrigerate at 2–8 °C and use within 30 days; do not freeze; protect from prolonged light exposure\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003cbr\u003e- For laboratory research use only.\u003cbr\u003e- Follow institutional biosafety, handling and waste disposal protocols.\u003cbr\u003e- Use appropriate PPE (gloves, lab coat, eye protection) when handling lyophilized powder and reconstituted solutions.\u003cbr\u003e- Avoid inhalation and contact with skin or eyes. In case of exposure follow institutional procedures.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003cbr\u003eQ: Is 0.25 mg of each peptide a suitable starting research dose?\u003cbr\u003eA: Many protocols reference 0.25 mg per peptide as a conservative investigational starting point; dose selection should be determined by study objectives and approved by oversight bodies.\u003c\/p\u003e\n\u003cp\u003eQ: When is dosing typically administered in research protocols?\u003cbr\u003eA: Nighttime dosing before sleep on an empty stomach is common to align with physiological GH release, though experimental designs may vary.\u003c\/p\u003e\n\u003cp\u003eQ: How soon might effects be observed in preclinical models?\u003cbr\u003eA: Improvements in recovery and body composition markers may be observed within weeks depending on model, dosing and concurrent interventions such as exercise.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003cbr\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52587149230369,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/cjc1295_ipamorelin_21351a71-6179-405f-a525-0b9ec8f1f85d.jpg?v=1776744630"},{"product_id":"cagrisema-metabolic-mastery-solution","title":"CagriSema Metabolic Mastery Solution","description":"\u003cp\u003eCagrilintide and Semaglutide (CagriSema) 5mg\/5mg Lyophilized Vial\u003c\/p\u003e\n\u003cp\u003eCagrilintide and Semaglutide, collectively referred to as CagriSema, is a research-grade dual-agonist peptide blend designed for metabolic health and weight management. This powerful combination includes an acylated amylin analogue (Cagrilintide) and a GLP-1 receptor agonist (Semaglutide) to enhance satiety and regulate appetite effectively.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research-grade peptide blend (batch-tested purity)\u003cbr\u003e- Combines Cagrilintide (coordinated gastric emptying) and Semaglutide (GLP-1 mimicking) for enhanced weight management\u003cbr\u003e- Promotes significant weight loss and better metabolic health in research settings\u003cbr\u003e- Supplied lyophilized for investigator-controlled reconstitution and dosing\u003cbr\u003e- Typical format: 5mg Cagrilintide and 5mg Semaglutide per vial for research use\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: Cagrilintide and Semaglutide (CagriSema) Blend (5 mg + 5 mg) (Purity: \u0026gt;99+% HPLC)\u003cbr\u003e- Category: Metabolic health research compound\u003cbr\u003e- Supplied in: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3ml bac water\u003c\/strong\u003e\u003c\/em\u003e\u003cbr\u003e- Typical Administration (Research): Subcutaneous injection (as per study protocol)\u003cbr\u003e- Storage (Reconstituted): Refrigerate at 2–8 °C; use within 30 days; avoid freeze-thaw cycles\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003eCagrilintide and Semaglutide engage dual physiological pathways. Cagrilintide activates amylin receptors to slow gastric emptying and signal fullness, while Semaglutide mimics GLP-1 to enhance satiety and reduce food intake. This combined activity results in greater metabolic control and weight loss efficacy compared to using either peptide alone.\u003c\/p\u003e\n\u003cp\u003ePotential Research Applications\u003c\/p\u003e\n\u003cp\u003e- Weight management and obesity treatment studies\u003cbr\u003e- Investigating appetite regulation and satiety mechanisms\u003cbr\u003e- Metabolic health and insulin sensitivity research\u003cbr\u003e- Endocrinology and diabetes model evaluations\u003cbr\u003e- Preclinical studies assessing dual-agonist therapies\u003c\/p\u003e\n\u003cp\u003eSuggested Research Notes \u0026amp; Dosing Context\u003c\/p\u003e\n\u003cp\u003e- Reconstitution: Reconstitute with 3 mL of Bacteriostatic Water (BAC) to the 5mg\/5mg lyophilized vial.\u003cbr\u003e- Dosing:\u003cbr\u003e  - Starting Dose: It is commonly recommended to initiate treatment with a lower dose of 1.25 mg (0.625 mg each of Cagrilintide and Semaglutide) per week, depending on individual tolerance and study protocol.\u003cbr\u003e  - Titration: The dosage may be gradually increased to a target maintenance dose of up to 2.5 mg (1.25 mg of each compound) per week.\u003cbr\u003e  - Administration Example: Administer the entire reconstituted 5mg vial over the week, adjusting according to participant needs and specific study objectives.\u003cbr\u003e  - Missed Dose: If a dose is missed, it should be administered as soon as possible within 3 days (72 hours) of the missed dose.\u003cbr\u003e  \u003cbr\u003e- Concentration: \u003cbr\u003e  - 10 mg total peptide per 3 mL = 3.33 mg\/mL. \u003cbr\u003e  - Volume for 1 mg: 1 mL \/ 3.33 = 0.3 mL. \u003cbr\u003e  - Volume for 2 mg: 2 × 0.3 mL = 0.6 mL.\u003cbr\u003e  - In insulin syringe units (100 units = 1 mL): 0.6 mL = 60 units.\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003c\/p\u003e\n\u003cp\u003eCagriSema effectively activates pathways linked to weight management and metabolic health. With confirmed improvements in body weight and metabolic markers in controlled trials, this combination serves as a valuable tool for exploring dual receptor agonists in research.\u003c\/p\u003e\n\u003cp\u003eKey Weight Loss Results and Timeline for CagriSema\u003c\/p\u003e\n\u003cp\u003e- Average Weight Loss: Participants in the Phase 3 REDEFINE 1 trial experienced an average weight reduction of 20.4% to 22.7% after 68 weeks.\u003cbr\u003e- Extended Timeline: In the REDEFINE 4 trial, extending to 84 weeks, CagriSema led to approximately 23% weight loss.\u003cbr\u003e- High Responders: Nearly 60% of participants in some trials achieved a weight loss of 20% or more, while over 40% lost 25% or more of their body weight.\u003cbr\u003e- Comparison to Wegovy: CagriSema demonstrated greater efficacy compared to semaglutide (Wegovy) alone, which typically led to lower percentage weight losses in similar trials.\u003cbr\u003e  \u003cbr\u003eKey Findings (2026 Update)\u003cbr\u003e- Type 2 Diabetes: CagriSema produced superior weight loss of up to 14.2% in patients with type 2 diabetes after 68 weeks, as shown in the REIMAGINE 2 trial.\u003cbr\u003e- Composition of Weight Loss: Data indicated that 66.9% of the weight lost was attributed to fat mass, with a total reduction in fat mass of 35.7%.\u003cbr\u003e- Regulatory Status: Novo Nordisk submitted CagriSema for FDA approval in December 2025, with a decision anticipated by late 2026.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events\u003c\/p\u003e\n\u003cp\u003e- Monitor for potential gastrointestinal side effects, including nausea and vomiting.\u003cbr\u003e- Safety profile may vary based on dosage and species in experimental settings.\u003cbr\u003e- Regular assessment of metabolic parameters is recommended.\u003c\/p\u003e\n\u003cp\u003eStorage, Stability, and Handling After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Store reconstituted solutions in the refrigerator at 2–8 °C and use within 30 days; do not freeze.\u003cbr\u003e- Protect from light and minimize freeze-thaw cycles.\u003cbr\u003e- Employ aseptic techniques during handling.\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003c\/p\u003e\n\u003cp\u003e- For laboratory research use only.\u003cbr\u003e- Follow institutional biosafety and chemical handling protocols.\u003cbr\u003e- Use appropriate personal protective equipment (PPE) such as gloves, lab coats, and safety goggles.\u003cbr\u003e- In case of accidental exposure, follow institutional incident procedures.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are using it for lawful research purposes. It is the purchaser's responsibility to ensure compliance with local laws and institutional policies. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52682538909985,"sku":null,"price":80.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/cagrisema10.jpg?v=1778729905"},{"product_id":"reta-body-sculpting-solution","title":"Reta Body Sculpting Solution","description":"\u003cp\u003eRetatrutide 60mg - Lyophilized Vial\u003c\/p\u003e\n\u003cp\u003eRetatrutide is a multi‑receptor agonist designed to engage incretin and related receptors that regulate appetite, energy expenditure and glucose metabolism. By simultaneously modulating these pathways, it is intended to produce greater weight‑loss and metabolic benefits compared with single‑target agents.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research‑grade retatrutide with documented purity  \u003cbr\u003e- Investigational activity on metabolic pathways relevant to weight management and glycemic control  \u003cbr\u003e- Shows potential to reduce body weight and improve metabolic parameters in experimental settings  \u003cbr\u003e- May support research into regenerative metabolic therapies and anti‑aging metabolic optimization  \u003cbr\u003e- Supplied as lyophilized vial(s) for reconstitution in laboratory environments\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product name: Retatrutide (investigational metabolic peptide) (Purity: \u0026gt;99+% HPLC) \u003cbr\u003e- Category: Metabolic \/ investigational peptide (research)  \u003cbr\u003e- Supplied in: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3ml bac water\u003c\/strong\u003e\u003c\/em\u003e \u003cbr\u003e- Typical administration (research): Subcutaneous injection per protocol  \u003cbr\u003e- Storage (reconstituted): Refrigerate at 2 - 8 °C; follow institutional SOPs for validated stability and avoid repeated freeze–thaw cycles\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003eKey Benefits\u003c\/p\u003e\n\u003cp\u003e- Substantial Weight Reduction: Clinical trials demonstrate highly effective weight loss, with higher doses yielding an average reduction of up to 24% body weight in 48 weeks.\u003cbr\u003e- Enhanced Glycemic Control: It significantly lowers HbA1c levels, with early data showing that up to 72% of prediabetic patients achieve normal blood sugar ranges.\u003cbr\u003e- Visceral \u0026amp; Liver Fat Reduction: It promotes a dramatic drop in ectopic fat, potentially reducing liver fat by up to 86% and deep abdominal fat by 48%.\u003cbr\u003e- Metabolic \u0026amp; Cardiovascular Markers: Improves lipid profiles, reduces blood pressure, and helps alleviate systemic inflammation.Potential Organ \u0026amp; Systemic Support: Ongoing studies are exploring its additional benefits for knee osteoarthritis pain, non-alcoholic fatty liver disease (NAFLD), and sleep apnea.\u003c\/p\u003e\n\u003cp\u003eReconstitution \u0026amp; Dosing Guide\u003c\/p\u003e\n\u003cp\u003eImportant: The following examples are for laboratory reference only. Confirm all calculations, aseptic technique and solvent compatibility with your institutional SOPs before use. Adjust volumes and concentrations according to the vial strength provided by your supplier.\u003c\/p\u003e\n\u003cp\u003eExample Reconstitution\u003c\/p\u003e\n\u003cp\u003eBelow are straightforward conversions and common dosing examples for a 60 mg vial reconstituted with 3.0 mL bacteriostatic water (resulting concentration: 60 mg ÷ 3.0 mL = 20 mg\/mL). Use only for informational\/research planning — verify calculations and follow institutional SOPs.\u003c\/p\u003e\n\u003cp\u003eConcentration\u003c\/p\u003e\n\u003cp\u003e- 20 mg\/mL (20,000 µg\/mL)\u003c\/p\u003e\n\u003cp\u003eVolume-to-dose conversions (mg → mL → U‑100 insulin units)\u003c\/p\u003e\n\u003cp\u003e- 0.4 mg = 0.02 mL = 2 units  \u003cbr\u003e- 0.8 mg = 0.04 mL = 4 units  \u003cbr\u003e- 1.2 mg = 0.06 mL = 6 units  \u003cbr\u003e- 1.6 mg = 0.08 mL = 8 units  \u003cbr\u003e- 2.0 mg = 0.10 mL = 10 units\u003c\/p\u003e\n\u003cp\u003eRange and Frequency\u003c\/p\u003e\n\u003cp\u003eStarting \/ low exploratory dose: approximately 0.4 mg (400 µg) once daily\u003cbr\u003eTypical escalation steps: 0.4 → 0.8 → 1.2 → 1.6 → 2.0 → 2.4 mg (increments and cadence depend on protocol)\u003cbr\u003eDosing frequency in studies: once daily subcutaneous injection\u003c\/p\u003e\n\u003cp\u003eTypical Titration Approach in Trials\u003c\/p\u003e\n\u003cp\u003eUse a conservative starting dose (e.g., 0.4 mg\/day) and predefined titration steps in your protocol.\u003cbr\u003eAllow 1–4 weeks between dose escalations to assess tolerability; length depends on the expected side‑effect profile and study design.\u003cbr\u003eDefine stopping rules for adverse events and criteria for dose reduction.\u003cbr\u003eMonitor weight, appetite, GI symptoms, blood glucose, and any other protocol‑specified biomarkers.\u003c\/p\u003e\n\u003cp\u003eCycle Length and Duration\u003c\/p\u003e\n\u003cp\u003eTreatment periods in trials commonly range from 12 weeks up to 48 weeks depending on endpoints; early‑phase dose‑finding cohorts often use 4–12 week blocks per dose level.\u003cbr\u003eThere is typically no short “on\/off” cycling; continuous daily dosing is the norm while titrating.\u003c\/p\u003e\n\u003cp\u003eSafety \/ Tolerability Notes\u003c\/p\u003e\n\u003cp\u003e- Beneficial effects: reduced appetite, weight loss, improved glycemic markers and insulin sensitivity and changes in energy expenditure.  \u003cbr\u003e- Possible adverse events: gastrointestinal symptoms, transient headache, injection‑site reactions and glycemic changes. Monitor for hypoglycemia if combined with other glucose‑lowering agents.  \u003cbr\u003e- Document and monitor all adverse events according to institutional safety procedures.\u003c\/p\u003e\n\u003cp\u003eAdministration Notes\u003c\/p\u003e\n\u003cp\u003e- Subcutaneous injection is the typical route in research protocols; timing (morning vs evening), frequency, and titration depend on study aims and safety data.  \u003cbr\u003e- Consider gradual dose escalation protocols to monitor tolerability and metabolic responses.  \u003c\/p\u003e\n\u003cp\u003eCycle Length and Scheduling\u003c\/p\u003e\n\u003cp\u003e- Cycle lengths vary by study design; many metabolic peptide studies use daily or weekly dosing schedules depending on pharmacokinetics.  \u003cbr\u003e- Tapering may not be required but should be defined in the protocol to minimize rebound effects.\u003c\/p\u003e\n\u003cp\u003eHandling, Stability and Storage After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Reconstituted solutions: refrigerate (2–8 °C)\u003cbr\u003e- Use aseptic technique, sterile syringes and needles for preparation and dosing.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003c\/p\u003e\n\u003cp\u003eQ: What dose should be used?  \u003cbr\u003eA: Dose selection must be based on supplier potency data, preclinical pharmacology, and an approved study protocol. Begin with conservative doses and escalate carefully under monitoring.\u003c\/p\u003e\n\u003cp\u003eQ: How is retatrutide administered?  \u003cbr\u003eA: Subcutaneous injection is standard in research; alternative routes depend on formulation and experimental design.\u003c\/p\u003e\n\u003cp\u003eQ: Can it be combined with other metabolic agents?  \u003cbr\u003eA: Combination studies are common but require careful monitoring for additive effects on glucose and other systems.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52682774774049,"sku":null,"price":140.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/retatrutide60.jpg?v=1778730705"},{"product_id":"aicar-performance-optimization","title":"AICAR Performance Optimization","description":"\u003cp\u003eAICAR (5‑Aminoimidazole‑4‑carboxamide ribonucleotide) 50 mg Lyophilized Vial\u003c\/p\u003e\n\u003cp\u003eAICAR is a research‑grade metabolic modulator supplied as a lyophilized powder for investigator‑controlled reconstitution. As an AMPK activator, AICAR mimics aspects of cellular low‑energy signaling to promote glucose uptake, increase fat oxidation and support mitochondrial function.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research‑grade metabolic activator (batch‑tested purity)\u003cbr\u003e- Potent activator of AMPK (cellular energy sensor)\u003cbr\u003e- Enhances glucose uptake and fatty‑acid oxidation in experimental models\u003cbr\u003e- Supports mitochondrial biogenesis and cellular energy regulation\u003cbr\u003e- Supplied lyophilized for custom reconstitution and dosing\u003cbr\u003e- Typical format: 50 mg vial for research use\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product name: AICAR (5‑Aminoimidazole‑4‑carboxamide ribonucleotide) (Purity: \u0026gt;99+% HPLC)\u003cbr\u003e- Category: Cellular \u0026amp; metabolic research compound\u003cbr\u003e- Supplied in: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3ml bac water\u003c\/strong\u003e\u003c\/em\u003e\u003cbr\u003e- Typical administration (research): Subcutaneous injection (model‑dependent)\u003cbr\u003e- Storage (reconstituted): Refrigerate at 2–8 °C; use within 30 days; avoid freeze–thaw cycles\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003eAICAR is converted intracellularly to ZMP, which activates AMPK — a master regulator of cellular energy balance. AMPK activation shifts metabolism toward increased glucose uptake and fatty‑acid oxidation, promotes mitochondrial efficiency and can trigger downstream pathways associated with improved metabolic resilience.\u003c\/p\u003e\n\u003cp\u003eKey Metabolic and Physical Benefits\u003c\/p\u003e\n\u003cp\u003e- Enhanced Endurance: By stimulating the creation of new mitochondria (mitochondrial biogenesis) and boosting fatty acid oxidation, AICAR helps cells generate energy more efficiently. In preclinical animal research, this translated to significantly improved running endurance without prior training.\u003cbr\u003e- Fat Loss \u0026amp; Weight Management: It shifts the body's primary energy source from glucose to fats, assisting in the breakdown of visceral fat and reducing overall body weight in subjects with metabolic syndrome.\u003cbr\u003e- Improved Insulin Sensitivity: Research shows it promotes glucose uptake in skeletal muscle, normalizing blood sugar levels and improving glucose tolerance in obesity-induced insulin-resistant models.Reduced Inflammation: It has anti-inflammatory properties that can help protect organs from obesity-induced damage and combat chronic inflammation linked to metabolic diseases.\u003c\/p\u003e\n\u003cp\u003eSuggested Research Notes \u0026amp; Dosing Context\u003c\/p\u003e\n\u003cp\u003e- Research-only low-dose protocols: some experimental setups use 0.5–1.0 mg per day in humans for exploratory metabolic research, but data is sparse and not standardized.\u003cbr\u003eReconstitution Instructions for AICAR (50mg Vial)\u003c\/p\u003e\n\u003cp\u003e- Reconstitution: Reconstitute with 3 mL of Bacteriostatic Water (BAC) to the 50 mg of AICAR.\u003cbr\u003e- Concentration:\u003cbr\u003e- After reconstitution: 50 mg \/ 3 mL = 16.67 mg\/mL.\u003c\/p\u003e\n\u003cp\u003e- Volume Calculations for Dosing:\u003cbr\u003e- Volume for 1 mg: 3 mL \/ 50 mg = 0.06 mL (approximately 0.06 mL per 1 mg).\u003cbr\u003e- Volume for 2 mg: 2 × 0.06 mL = 0.12 mL (approximately 0.12 mL per 2 mg).\u003c\/p\u003e\n\u003cp\u003e- In Insulin Syringe Units (100 units = 1 mL):\u003cbr\u003e- For 1 mg: 0.06 mL = 6 units.\u003cbr\u003e- For 2 mg: 0.12 mL = 12 units.\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003c\/p\u003e\n\u003cp\u003e- AICAR reliably activates AMPK in controlled settings, producing measurable effects on glucose transport, fatty‑acid oxidation and markers of mitochondrial activity.\u003cbr\u003e- Because AMPK is a central metabolic regulator, AICAR is a useful tool to probe energy‑sensing pathways and downstream metabolic adaptations in cells and animal models.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events\u003c\/p\u003e\n\u003cp\u003e- Model‑dependent effects; safety profile varies with dose and species\u003cbr\u003e- High experimental doses in animal work exceed any established safe human dose\u003cbr\u003e- Monitor metabolic parameters and overall health markers in study subjects\u003c\/p\u003e\n\u003cp\u003eStorage, Stability and Handling After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Reconstituted solutions: refrigerate at 2–8 °C and use within 30 days; protect from light; do not freeze\u003cbr\u003e- Minimize freeze–thaw cycles and employ aseptic technique during handling\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003c\/p\u003e\n\u003cp\u003e- For laboratory research use only.\u003cbr\u003e- Follow institutional biosafety, chemical handling and waste disposal protocols.\u003cbr\u003e- Use appropriate personal protective equipment (PPE) such as gloves, lab coat and eye protection.\u003cbr\u003e- In case of accidental exposure follow institutional incident procedures.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52683100029217,"sku":null,"price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/aicar50.jpg?v=1778731908"},{"product_id":"kisspeptin-revitalized-fertility-solution","title":"Kisspeptin Revitalized Fertility Solution","description":"\u003cp\u003eKisspeptin 10mg Lyophilized Vial\u003c\/p\u003e\n\u003cp\u003eKisspeptin is a research-grade peptide known for its role in reproductive health, acting as a key regulator in the hypothalamic-pituitary-gonadal (HPG) axis. This potent 10mg lyophilized vial of Kisspeptin is designed for controlled reconstitution and dosing in research settings, facilitating studies in endocrine regulation and fertility.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research-grade peptide (batch-tested for purity)\u003cbr\u003e- Critical role in the activation of the HPG axis\u003cbr\u003e- Enhances the release of gonadotropin-releasing hormone (GnRH)\u003cbr\u003e- Supplied lyophilized for custom reconstitution and dosing\u003cbr\u003e- Typical format: 10mg vial for research use\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: Kisspeptin (Purity: \u0026gt;99+% HPLC)\u003cbr\u003e- Category: Reproductive health research compound\u003cbr\u003e- Supplied in: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3ml bac water\u003c\/strong\u003e\u003c\/em\u003e\u003cbr\u003e- Typical Administration (Research): Subcutaneous or intravenous injection (as per study protocol)\u003cbr\u003e- Storage (Reconstituted): Refrigerate at 2–8 °C; use within 30 days; avoid freeze-thaw cycles\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003eKisspeptin is essential for the activation of the GnRH neurons, initiating the reproductive hormone cascade. By stimulating the release of GnRH, Kisspeptin indirectly affects the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), playing a crucial role in regulating puberty and fertility.\u003c\/p\u003e\n\u003cp\u003eKey Benefits of Kisspeptin\u003c\/p\u003e\n\u003cp\u003e- Enhanced Sexual Function \u0026amp; Libido: Clinical trials showed that kisspeptin acts on key brain regions to increase sexual arousal, libido, and drive in both men and women with low sex drive (Hypoactive Sexual Desire Disorder - HSDD).\u003cbr\u003e- Increased Penile Tumescence: Studies demonstrated that kisspeptin increases penile rigidity (by up to 56%) in response to sexual stimuli.\u003cbr\u003e- Boosted Reproductive Hormones: It stimulates the release of GnRH, resulting in increased LH and FSH, which elevates natural testosterone production.\u003cbr\u003e- Infertility Management: It shows potential for triggering ovulation in women, including those at high risk of ovarian hyperstimulation syndrome.\u003cbr\u003e- Improved Mood and Emotional Response: Studies found that kisspeptin may boost \"happiness about sex\" and improve romantic, emotional brain processing.\u003cbr\u003e- Possible Anti-Tumor Effects: Early research suggests it can inhibit the metastasis of certain cancers.\u003c\/p\u003e\n\u003cp\u003eSuggested Research Notes \u0026amp; Dosing Context\u003c\/p\u003e\n\u003cp\u003e- Reconstitution: Reconstitute with 1–2 mL of Bacteriostatic Water (BAC) to the 10mg lyophilized vial.\u003cbr\u003e- Dosing:\u003cbr\u003e  - Starting Dose: Commonly, a starting dose may range from 0.5 to 2.0 mg, depending on individual protocols and research objectives.\u003cbr\u003e  - Administration Example: For a dose of 1 mg, if 1 mL of BAC is used for reconstitution, draw 0.1 mL from the vial (which will equal 1 mg of Kisspeptin).\u003cbr\u003e  \u003cbr\u003e- Concentration: \u003c\/p\u003e\n\u003cp\u003e  - After reconstitution with 1 mL of BAC: 10 mg\/1 mL = 10 mg\/mL.\u003cbr\u003e  - Volume per dose: For a 1 mg dose, draw 0.1 mL from the vial.\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003c\/p\u003e\n\u003cp\u003eKisspeptin is a pivotal peptide that has garnered attention for its role in stimulating reproductive hormone release and addressing conditions linked to fertility and sexual maturation. Investigating Kisspeptin can provide valuable insights into the neuroendocrine mechanisms governing reproduction and associated behaviors.---\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events \u003c\/p\u003e\n\u003cp\u003e- Potential minor side effects may include injection site reactions or transient changes in hormone levels.\u003cbr\u003e- Safety profiles should be established in study participants through careful monitoring of endocrine responses and overall health indicators.\u003c\/p\u003e\n\u003cp\u003eStorage, Stability and Handling After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Store reconstituted solutions in the refrigerator at 2–8 °C and use within 30 days; do not freeze.\u003cbr\u003e- Protect from light and minimize freeze-thaw cycles.\u003cbr\u003e- Employ aseptic techniques during handling.\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003c\/p\u003e\n\u003cp\u003e- For laboratory research use only.\u003cbr\u003e- Follow institutional biosafety and chemical handling protocols.\u003cbr\u003e- Use appropriate personal protective equipment (PPE) such as gloves, lab coats and safety goggles.\u003cbr\u003e- In case of accidental exposure, follow institutional incident procedures.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are using it for lawful research purposes. It is the purchaser's responsibility to ensure compliance with local laws and institutional policies. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52683214356769,"sku":null,"price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/kisspeptin10.jpg?v=1778732843"},{"product_id":"3ml-ez-refillable-pressure-injection-pen","title":"3ml EZ Refillable Pressure Injection Pen","description":"\u003cp\u003eRefillable Pen with Hard (Protective) Casing Only\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eA \u003c\/span\u003e\u003cspan class=\"font-semibold\" data-streamdown=\"strong\"\u003erefillable pressure injection pen\u003c\/span\u003e\u003cspan\u003e is designed for precise self-administration of medications, featuring accurate dosing units that allow users to measure their doses clearly. These pens typically use replaceable 3ml cartridges and are ideal for various injectable medications, including insulin and other chronic treatments.\u003c\/span\u003e\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52697075745057,"sku":null,"price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/rn-image_picker_lib_temp_bb723e52-e6fc-440d-86b3-d24de04daab9.jpg?v=1778893307"},{"product_id":"pen-cartridge","title":"Pen Cartridge","description":"\u003cp\u003e\u003cem\u003e\u003cstrong\u003eThe price listed is for 10 Cartridges\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e3 ml empty refillable cartridges (often referred to as empty cassette bottles or glass cartridges) for use with reusable insulin and peptide pens. These cartridges allow users to transfer insulin or peptides from a larger vial into a standard 3 ml format compatible with many pen brands.\u003c\/p\u003e\n\u003cp\u003eWhen choosing a 3 ml refillable cartridge, keep the pen compatibility requirements in mind.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699081113889,"sku":null,"price":9.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/cart3.jpg?v=1778993679"},{"product_id":"na-semax-nh2-the-focus-formula","title":"NA-Semax-NH2 The Focus Formula","description":"\u003cp\u003e NA-Semax-NH2 10mg\u003c\/p\u003e\n\u003cp\u003eNA-Semax-NH2 is the latest variant of Semax, synthetic peptide designed for its nootropic and neuroprotective properties. It enhances cognitive function, improves memory, and supports recovery from neurological conditions. Supplied as a lyophilized powder for investigator-controlled reconstitution, NA-Semax-NH2 aims to optimize brain health and bolster cognitive performance.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Neuroprotective peptide that promotes cognitive enhancement\u003cbr\u003e- Improves memory and learning capabilities\u003cbr\u003e- Supports recovery from neurological conditions\u003cbr\u003e- Supplied lyophilized for custom reconstitution and dosing\u003cbr\u003e- Available vial size: 10 mg\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: NA-Semax-NH2 10 mg (Purity: \u0026gt;99% HPLC)\u003cbr\u003e- Category: Nootropic peptide  \u003cbr\u003e- Supplied in: \u003cem\u003e\u003cstrong\u003eLyophilized powder in sterile vial + 3ml bac water \u003c\/strong\u003e\u003c\/em\u003e\u003cbr\u003e- Administration: Intranasal or subcutaneous injection (typical)  \u003cbr\u003e- Storage (reconstituted): Store at 2–8 °C\u003c\/p\u003e\n\u003cp\u003eMechanism of Action:\u003c\/p\u003e\n\u003cp\u003eCore Benefits\u003c\/p\u003e\n\u003cp\u003e- Advanced Cognitive Enhancement: Promotes increased levels of Brain-Derived Neurotrophic Factor (BDNF), aiding in neuroplasticity, memory retention, and improved focus\/attention.\u003cbr\u003e- Mental Clarity: Users frequently report a reduction in mental fog and \"brain static,\" making it easier to initiate and sustain focus on complex tasks.\u003cbr\u003e- Mood Stabilization: Interacts with the dopaminergic and serotonergic systems, which helps reduce symptoms of mild-to-moderate anxiety and promotes emotional resilience.\u003cbr\u003e- Neuroprotection: Protects neurons from oxidative stress and inflammation while enhancing cerebral blood flow. It has historically been used clinically in Russia for stroke rehabilitation and optic nerve health.\u003c\/p\u003e\n\u003cp\u003eReconstitution \u0026amp; Dosing Guide\u003c\/p\u003e\n\u003cp\u003eImportant: The following examples are for laboratory reference only. Validate all calculations, aseptic technique, and solvent compatibility with your institutional protocols before use.\u003c\/p\u003e\n\u003cp\u003eExample Reconstitution (10 mg vial + 3 mL sterile saline)  \u003cbr\u003e- Resulting concentration: 3.33 mg\/mL  \u003cbr\u003e- Example dosing volumes (U-100 insulin syringe reference):  \u003cbr\u003e  - 1 mg = 0.30 mL (30 units)  \u003cbr\u003e  - 2 mg = 0.60 mL (60 units)  \u003cbr\u003e  - 5 mg = 1.50 mL (150 units)  \u003c\/p\u003e\n\u003cp\u003eSuggested Research Protocol  \u003cbr\u003e- Typical investigational dose range reported in experimental contexts: 1–10 mg per administration  \u003cbr\u003e- Common schedule used in research: 1-3 times daily to support cognitive function and neuroprotection  \u003cbr\u003e- Cycle lengths in study designs: 3–8 weeks on with 4 weeks off; tapering generally not required  \u003cbr\u003e- Protocols should be designed and approved by qualified investigators and institutional oversight\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003c\/p\u003e\n\u003cp\u003eNA-Semax-NH2 has been shown to facilitate the recovery of cognitive functions through its neuroprotective effects. Research indicates its potential in enhancing learning ability and memory retention, as well as providing protective measures against stress and cognitive decline.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events (Preclinical\/Experimental Context)\u003c\/p\u003e\n\u003cp\u003e- Mild local irritation at the injection site  \u003cbr\u003e- Rarely, headache or dizziness may be reported\u003c\/p\u003e\n\u003cp\u003eStorage, Stability, and Handling After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Reconstituted solutions: store at 2–8 °C and protect from prolonged light exposure. Use within 30 days for best results.\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003c\/p\u003e\n\u003cp\u003e- Follow institutional biosafety, handling, and waste disposal protocols. Ensure compliance with local laws and regulations.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003c\/p\u003e\n\u003cp\u003eQ: Is 1 mg a reasonable starting research dose?  \u003cbr\u003eA: Many protocols begin conservatively at 1-2 mg; dose selection should align with study objectives and institutional approvals.\u003c\/p\u003e\n\u003cp\u003eQ: Can NA-Semax-NH2 be dosed multiple times daily?  \u003cbr\u003eA: Yes — it is commonly administered 1-3 times daily depending on desired cognitive enhancement effects.\u003c\/p\u003e\n\u003cp\u003eQ: When might effects be observed?  \u003cbr\u003eA: Improvements in cognitive function and memory can be noticeable within a few days, depending on individual responses and specific interventions.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical, and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699094941985,"sku":null,"price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/na-semax-nh210.jpg?v=1778994398"},{"product_id":"pnc-27-for-health-and-oncology-support","title":"PNC-27 for Health and Oncology Support","description":"\u003cp\u003ePNC-27 10mg\u003c\/p\u003e\n\u003cp\u003ePNC-27 is a research-grade peptide that has gained attention for its potential benefits in cancer research, particularly in its role as an anti-cancer agent. This peptide is intended for laboratory and preclinical research applications.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research-grade peptide (99+% purity, third-party tested)\u003cbr\u003e- Investigated for in medical oncology for potential anti-cancer properties \u003cbr\u003e- Lyophilized for investigator-controlled reconstitution and dosing\u003cbr\u003e- Available format: 10 mg total\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: PNC-27 10mg (Purity: \u0026gt;99+% HPLC)\u003cbr\u003e- Category: Anti-cancer peptide (research chemical)\u003cbr\u003e- Supplied in: Lyophilized powder in sterile vial + 3 mL bacteriostatic water\u003cbr\u003e- Administration (research\/preclinical): Subcutaneous injection preferred\u003cbr\u003e- Storage (reconstituted): Refrigerate at 2–8 °C; use within 30 days; avoid freeze-thaw cycles\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003ePNC-27 is an experimental anti-cancer peptide. Its primary function and reported benefits in early research include:\u003c\/p\u003e\n\u003cp\u003e- Selective Cancer Cell Destruction: It binds to the HDM-2 protein located on the membranes of cancer cells, which forms pores and causes the cancer cell to rupture and die (necrosis).\u003cbr\u003e- Safety for Healthy Cells: In laboratory studies, PNC-27 selectively targets and kills cancer cells while leaving normal, untransformed cells unharmed.\u003cbr\u003e- Broad Efficacy: Research indicates it is cytotoxic to a variety of cancer types, including breast, pancreatic, cervical, and melanoma, as well as multiple myeloma.\u003cbr\u003e- Synergy with Metabolic Therapy: Some recent studies suggest that combining PNC-27 with ketone bodies (like lithium acetoacetate) can significantly enhance the peptide's effectiveness at lower doses. \u003cbr\u003e- Potential for Decreased Tumor Viability: Preliminary studies indicate that PNC-27 may inhibit tumor growth and enhance the efficacy of existing cancer treatments, making it an exciting candidate for further research in oncology.\u003c\/p\u003e\n\u003cp\u003eDosing Guide\u003c\/p\u003e\n\u003cp\u003ePNC-27 is typically administered via subcutaneous injection. The recommended dosing regimen is as follows:\u003c\/p\u003e\n\u003cp\u003e- Initial Dose: For most research applications, the initial dose typically ranges from 0.5 to 2.0 mg, which translates to:\u003cbr\u003e  - 5 to 20 units on a U-100 insulin syringe (considering 1 mg = 10 units for a 10 mg\/mL solution).\u003cbr\u003e  \u003cbr\u003e- Maximum Dose: Do not exceed a recommended dose of 3.0 mg, which equals:\u003cbr\u003e  - 30 units on a U-100 insulin syringe.\u003cbr\u003e  \u003cbr\u003e- Frequency of Administration: PNC-27 can be administered up to once daily, based on individual tolerance and response, but should not be used more frequently than every 48 hours to assess effectiveness and avoid potential side effects.\u003c\/p\u003e\n\u003cp\u003eReconstitution Protocol (10mg Vial)\u003c\/p\u003e\n\u003cp\u003eFor optimal reconstitution, it is recommended to use bacteriostatic water.\u003c\/p\u003e\n\u003cp\u003e- Prep: Wipe the vial stoppers of both the PNC-27 and the bacteriostatic water with alcohol swabs.\u003cbr\u003e- Draw: Using a 1 mL or 3 mL syringe, draw 1.0 mL of bacteriostatic water.\u003cbr\u003e- Inject: Slowly inject the bacteriostatic water into the peptide vial, directing the stream to the side of the vial to avoid damaging the peptide structure.\u003cbr\u003e- Dissolve: Gently swirl the vial between your fingers. Do not shake. The solution should be clear.\u003cbr\u003e- Storage: Store reconstituted vials in a refrigerator at 2°C–8°C (39°F).\u003c\/p\u003e\n\u003cp\u003eThis results in a concentration of 10 mg\/mL (assuming a 10 mg vial reconstituted with 1 mL BAC water).\u003c\/p\u003e\n\u003cp\u003eSafety Information\u003c\/p\u003e\n\u003cp\u003e- Side Effects: Common side effects may include injection site reactions, nausea, and transient headaches.\u003cbr\u003e- Contraindications: Not recommended for individuals with uncontrolled hypertension or a history of cancer.\u003cbr\u003e- Health Warnings: Use caution in individuals with pre-existing medical conditions, and consult with a healthcare professional before starting any new peptide regimen.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical standards, and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699102871841,"sku":null,"price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/PNC2710.jpg?v=1778995522"},{"product_id":"pt-141-the-passion-and-arousal-peptide","title":"PT-141 The Passion and Arousal Peptide","description":"\u003cp\u003ePT-141 10mg\u003c\/p\u003e\n\u003cp\u003ePT-141, also known as Bremelanotide, is a research-grade peptide designed to enhance sexual function and improve libido. It is particularly noteworthy for its ability to stimulate desire and arousal in both men and women, making it an innovative option for those experiencing sexual dysfunction. This peptide is intended for laboratory and preclinical research applications.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research-grade peptide (99+% purity, third-party tested)\u003cbr\u003e- Enhances sexual function and libido\u003cbr\u003e- Mood and arousal enhancement\u003cbr\u003e- Supplied lyophilized for investigator-controlled reconstitution and dosing\u003cbr\u003e- Available format: 10 mg total\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e-  Product Name:  PT-141 10mg (Purity: \u0026gt;99+% HPLC)\u003cbr\u003e-  Category:  Sexual function enhancement peptide (research chemical)\u003cbr\u003e-  Supplied in: Lyophilized powder in sterile vial + 3ml bac water\u003cbr\u003e-  Administration (research\/preclinical):  Subcutaneous injection preferred\u003cbr\u003e-  Storage (reconstituted):  Refrigerate at 2–8 °C; use within 30 days; avoid freeze-thaw cycles\u003c\/p\u003e\n\u003cp\u003eCore Benefits\u003c\/p\u003e\n\u003cp\u003e- Increased Libido: By acting on the central nervous system, it directly stimulates the brain's natural arousal and desire pathways.\u003cbr\u003e- Erectile Dysfunction (ED) Relief: It triggers the release of nitric oxide, relaxing muscles and improving blood flow to assist with stronger, longer-lasting erections.\u003cbr\u003e- Alternative to PDE-5 Inhibitors: Unlike drugs such as Viagra or Cialis, PT-141 works on the brain rather than just dilating blood vessels, offering a solution for those who do not respond to traditional ED medications.\u003cbr\u003e- HSDD Treatment: It is FDA-approved under the brand name Vyleesi for treating Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.\u003cbr\u003e- Heightened Sensation \u0026amp; Mood: Users often report increased physical sensitivity and enhanced overall well-being.\u003cbr\u003e- Long-Lasting Effects: The effects can remain active anywhere from 4 to 72 hours, depending on the dosage and individual response.\u003c\/p\u003e\n\u003cp\u003eDosing Guide\u003c\/p\u003e\n\u003cp\u003ePT-141 is typically administered via subcutaneous injection. The recommended dosing regimen is as follows:\u003c\/p\u003e\n\u003cp\u003eInitial Dose:  For most research purposes, the initial dose typically ranges from  0.5 to 2.0 mg , which translates to:\u003cbr\u003e  -  5 to 20 units  on a U-100 insulin syringe (considering 1 mg = 10 units for a 10 mg\/mL solution).\u003cbr\u003eMaximum Dose:  Do not exceed a recommended dose of  3.0 mg , which equals:\u003cbr\u003e  -  30 units  on a U-100 insulin syringe.\u003cbr\u003e  \u003cbr\u003e  -  Frequency of Administration: PT-141 can be administered approximately 45 minutes prior to a desired intimate encounter for optimal effects. It may also be used once daily, depending on individual tolerance and response. However, it is recommended not to exceed administration more frequently than every 48 hours to ensure effective assessment and to minimize potential side effects.\u003c\/p\u003e\n\u003cp\u003eReconstitution Protocol (10mg Vial)\u003c\/p\u003e\n\u003cp\u003eFor optimal reconstitution, it is recommended to use Bacteriostatic Water.\u003c\/p\u003e\n\u003cp\u003e-  Prep:  Wipe the vial stoppers of both the PT-141 and the bacteriostatic water with alcohol swabs.\u003cbr\u003e-  Draw:  Using a 1mL or 3mL syringe, draw  1.0 mL  of bacteriostatic water.\u003cbr\u003e-  Inject:  Slowly inject the bacteriostatic water into the peptide vial, directing the stream to the side of the vial to avoid damaging the peptide structure.\u003cbr\u003e-  Dissolve:  Gently swirl the vial between your fingers. Do not shake. The solution should be clear.\u003cbr\u003e-  Storage:  Store reconstituted vials in a refrigerator at 2°C–8°C (39°F).\u003c\/p\u003e\n\u003cp\u003eThis results in a concentration of  10 mg\/mL  (assuming a 10 mg vial reconstituted with 1 mL BAC water).\u003c\/p\u003e\n\u003cp\u003e Safety Information\u003c\/p\u003e\n\u003cp\u003e-  Side Effects:  Common side effects may include nausea, flushing, and headaches; most are mild and transient.\u003cbr\u003e-  Contraindications:  Not recommended for individuals with uncontrolled hypertension or cardiovascular disease.\u003cbr\u003e-  Health Warnings:  Use caution in individuals with pre-existing medical conditions, and consult with a healthcare professional before starting any new peptide regimen.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical standards, and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699107590433,"sku":null,"price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/pt14110.jpg?v=1778996395"},{"product_id":"dihexa-neuro-enhancer","title":"Dihexa Neuro Enhancer","description":"\u003cp\u003eDihexa 10mg\u003c\/p\u003e\n\u003cp\u003eDihexa is a research-grade peptide specifically designed to enhance synaptic plasticity and support neurotrophic signaling. This innovative compound is characterized by its potential to enhance cognitive function and promote neurogenesis. Dihexa is intended for laboratory and preclinical research applications.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research-grade peptide (99+% purity, third-party tested)\u003cbr\u003e- Designed to enhance synaptic plasticity and cognitive function\u003cbr\u003e- Potential to promote neuronal growth and repair\u003cbr\u003e- Supplied lyophilized for investigator-controlled reconstitution and dosing\u003cbr\u003e- Available format: 10 mg total\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: Dihexa 10mg (Purity: \u0026gt;99+% HPLC)\u003cbr\u003e- Category: Cognitive enhancer and neurotrophic peptide (research chemical)\u003cbr\u003e- Supplied in: Lyophilized powder in sterile vial + 3ml bac water\u003cbr\u003e- Administration (research\/preclinical): Subcutaneous or intramuscular injection preferred\u003cbr\u003e- Storage (reconstituted): Refrigerate at 2–8 °C; use within 30 days; avoid freeze-thaw cycles\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003eCore Benefits\u003c\/p\u003e\n\u003cp\u003e- Cognitive Enhancement: Dihexa has been shown in animal models to improve learning, accelerate memory formation, and increase problem-solving capabilities.\u003cbr\u003e- Brain Repair \u0026amp; Neuroprotection: By binding to hepatocyte growth factor (HGF), it stimulates the growth of new synapses (synaptogenesis) and aids in restoring neural connectivity.\u003cbr\u003e- Potential Against Degenerative Disease: It shows promise in preclinical research for mitigating the effects of Alzheimer's and Parkinson's by addressing synaptic loss and inflammation.\u003cbr\u003e- Mental Endurance: Users and proponents of nootropic research often report increased mental stamina, reduced brain fog, and enhanced focus.\u003cbr\u003e- Mood Stabilization: Enhanced neural communication is frequently associated with improved emotional regulation and a reduction in depressive symptoms.\u003c\/p\u003e\n\u003cp\u003eReconstitution Protocol (10mg Vial)\u003c\/p\u003e\n\u003cp\u003eFor optimal results, use Bacteriostatic Water (water containing 0.9% benzyl alcohol) to maintain sterility.\u003c\/p\u003e\n\u003cp\u003e- Prep: Wipe the vial stoppers of both the Dihexa and the bacteriostatic water with alcohol swabs.\u003cbr\u003e- Draw: Using a 1mL or 3mL syringe, draw 2.0 mL of bacteriostatic water.\u003cbr\u003e- Inject: Slowly inject the bacteriostatic water into the peptide vial, directing the stream to the side of the vial to avoid damaging the peptide structure.\u003cbr\u003e- Dissolve: Gently swirl the vial between your fingers. Do not shake. The solution should be clear.\u003cbr\u003e- Storage: Store reconstituted vials in a refrigerator at 2°C–8°C (39°F).\u003c\/p\u003e\n\u003cp\u003eThis results in a concentration of 5 mg\/mL (assuming a 10mg vial reconstituted with 2mL BAC water).\u003c\/p\u003e\n\u003cp\u003eDosing and Usage Protocol\u003c\/p\u003e\n\u003cp\u003e- Administration: Dihexa is typically administered via subcutaneous (SQ) or intramuscular injection. The standard dosage for research applications commonly ranges from 1 to 5 mg per day, depending on the specific objectives and health conditions being addressed.\u003c\/p\u003e\n\u003cp\u003e- Dosing Schedule: Treatment courses are generally conducted in cycles of 20 days, with daily injections. Afterward, it is recommended to take a break of one to two months before repeating the cycle. In many cases, the cycle may be repeated 2 to 3 times a year as needed based on individual progress and evaluation.\u003c\/p\u003e\n\u003cp\u003e- Insulin Syringe Measurements (U-100, 1mL \/ 100 units):\u003c\/p\u003e\n\u003cp\u003e| Amount of BAC Water | Final Concentration | 5 mg Dose Amount (U-100 Syringe)|\u003cbr\u003e|---------------------|---------------------|---------------------------------|\u003cbr\u003e| 1.0 mL              | 10 mg\/mL            | 50 Units (0.5 mL)               |\u003cbr\u003e| 2.0 mL              | 5 mg\/mL             | 100 Units (1.0 mL)              |\u003c\/p\u003e\n\u003cp\u003e- Usage: For research applications, the compound is typically administered once daily based on individual study protocols and objectives.\u003c\/p\u003e\n\u003cp\u003eSafety Information\u003c\/p\u003e\n\u003cp\u003e- Side Effects: Minimal in studies; potential for mild side effects such as local irritation at the injection site.\u003cbr\u003e- Contraindications: Not recommended for use during pregnancy or while breastfeeding.\u003cbr\u003e- Health Warnings: Use caution in individuals with specific health conditions or those planning significant medical interventions.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical standards, and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699121746209,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/dihexa10.jpg?v=1779000925"},{"product_id":"cortagen-for-balance-boost","title":"Cortagen for Balance Boost","description":"\u003cp\u003eCortagen 10mg\u003c\/p\u003e\n\u003cp\u003eThe synthetic tetrapeptide Cortagen (Ala-Glu-Asp-Pro) was obtained by directed synthesis based on amino acid analysis of natural brain cortex peptide preparation Cortexin. In humans, Cortagen demonstrated a pronounced therapeutic effect upon the structural and functional posttraumatic recovery of peripheral nerve tissue.This peptide is intended for laboratory and preclinical research applications.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research-grade synthetic peptide (99+% purity, third-party tested)\u003c\/p\u003e\n\u003cp\u003e- Designed to improve neuroprotective, anti-inflammatory and tissue-regenerating properties\u003c\/p\u003e\n\u003cp\u003e- Potential for modulation of the stress response to improve overall wellness\u003c\/p\u003e\n\u003cp\u003e- Supplied lyophilized for investigator-controlled reconstitution and dosing\u003c\/p\u003e\n\u003cp\u003e- Available format: 10 mg total\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: Cortagen 10mg (Purity: \u0026gt;99+% HPLC)\u003c\/p\u003e\n\u003cp\u003e- Category: Peptide for health and performance enhancement (research chemical)\u003c\/p\u003e\n\u003cp\u003e- Supplied in: \u003cstrong\u003e\u003cem\u003eLyophilized powder in sterile vial + 3 mL bacteriostatic water\u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Administration (research\/preclinical): Preferred routes include subcutaneous or intramuscular injection\u003c\/p\u003e\n\u003cp\u003e- Storage (reconstituted): Refrigerate at 2–8 °C; use within 30 days; avoid freeze-thaw cycles\u003c\/p\u003e\n\u003cp\u003eMechanism of Action \u003c\/p\u003e\n\u003cp\u003eCortagen is a synthetic tetrapeptide (Ala-Glu-Asp-Pro) known for its neuroprotective, anti-inflammatory, and tissue-regenerating properties. Originally derived from brain cortex extracts, it is primarily studied for accelerating peripheral nerve repair, modulating immune responses, and supporting cognitive and cardiovascular functions.\u003c\/p\u003e\n\u003cp\u003eKey Benefits \u0026amp; Uses\u003c\/p\u003e\n\u003cp\u003e- Nerve Regeneration: Preclinical models show Cortagen can significantly accelerate the growth rate and conduction velocity of regenerating nerve fibers (e.g., sciatic nerve). It promotes post-traumatic structural repair of peripheral nerve tissues.Neuroprotection: It is frequently utilized in molecular research to support brain function, improve memory, and protect against oxidative stress.\u003cbr\u003e- Immune Support: Studies indicate Cortagen can positively modulate the immune system, such as significantly increasing the expression of the interleukin-2 (IL-2) gene, which is vital for white blood cell activity.\u003cbr\u003e- Behavioral \u0026amp; Mood Regulation: Unlike some natural brain cortex extracts that can trigger anxiety with repeated use, Cortagen provides motor stimulation and improved well-being without negative emotional side effects, making it an area of interest for managing depressive symptoms.\u003cbr\u003e- Cardiovascular \u0026amp; Cerebrovascular Health: Research shows Cortagen can affect gene expression in the heart and prevent the excessive activation of lipid peroxidation, which helps protect cardiovascular and cerebrovascular tissues from ischemic damage.\u003c\/p\u003e\n\u003cp\u003eDosage Information\u003c\/p\u003e\n\u003cp\u003eCortagen is typically administered via intramuscular or subcutaneous injection. For adults, the standard daily dose ranges from 0.1 mg to 5 mg, depending on the specific condition being treated. Treatment courses generally last up to 20 days, which may be repeated after a break of one to two months based on medical evaluation. It is common to repeat the cycle 2 to 3 times per year as needed.\u003c\/p\u003e\n\u003cp\u003eDosage regimens should be tailored to the individual's needs, with progress monitored to optimize therapeutic outcomes.\u003c\/p\u003e\n\u003cp\u003eReconstitution and Dosage Guide\u003c\/p\u003e\n\u003cp\u003eFor optimal results, use 2 mL of Bacteriostatic Water (water containing 0.9% benzyl alcohol) to maintain sterility. This results in a final concentration of 5 mg\/mL (assuming a 10 mg vial reconstituted with 2 mL BAC water).\u003c\/p\u003e\n\u003cp\u003eUsage Protocol (Using Insulin Syringe)\u003c\/p\u003e\n\u003cp\u003e- Administration: Subcutaneous (SQ) injection is typically performed into abdominal fat. The standard research-backed protocol consists of a 20-day cycle, repeated 2-3 times per year.\u003c\/p\u003e\n\u003cp\u003e- Insulin Syringe Measurements (U-100, 1 mL \/ 100 units):\u003c\/p\u003e\n\u003cp\u003e| Amount of BAC Water | Final Concentration | Dose Amount (U-100 Syringe) |\u003c\/p\u003e\n\u003cp\u003e|---------------------|---------------------|------------------------------|\u003c\/p\u003e\n\u003cp\u003e| 1.0 mL | 10 mg\/mL | 50 Units (0.5 mL) |\u003c\/p\u003e\n\u003cp\u003e| 2.0 mL | 5 mg\/mL | 100 Units (1.0 mL) |\u003c\/p\u003e\n\u003cp\u003e- Usage: For research applications, Cortagen is typically administered once daily based on individual study protocols.\u003c\/p\u003e\n\u003cp\u003eSafety Information\u003c\/p\u003e\n\u003cp\u003e- Side Effects: Minimal side effects reported in studies; potential for mild local irritation at the injection site.\u003c\/p\u003e\n\u003cp\u003e- Contraindications: Not recommended during pregnancy or while breastfeeding.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical standards, and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699128496417,"sku":null,"price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/cortagen10.jpg?v=1779003070"},{"product_id":"slu-pp-332-performax-and-stamina-surge","title":"SLU-PP-332 Performax and Stamina Surge","description":"\u003cp\u003eSLU-PP-332 1mg Capsules\u003c\/p\u003e\n\u003cp\u003eSLU-PP-332 is a cutting-edge research-grade compound designed to support enhanced health and wellness. Formulated for laboratory and preclinical research applications, each capsule delivers a precise dosage of 1 mg, facilitating controlled administration for various research protocols.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- High Purity: Research-grade compound with 99+% purity, verified through third-party testing.\u003cbr\u003e- Accurate Dosing: Each capsule contains 1 mg of SLU-PP-332, ensuring precise dosage for research purposes.\u003cbr\u003e- Convenient Form: Supplied in capsule form for ease of use and administration.\u003cbr\u003e- Multi-Application: Designed for laboratory and preclinical research applications.\u003cbr\u003e- Packaging: Available in bottles containing 60 capsules each.\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: SLU-PP-332 1mg Capsules\u003cbr\u003e- Category: Research chemical for health enhancement\u003cbr\u003e- Supplied In: Bottled capsules (60 capsules per bottle)\u003cbr\u003e- Administration: Oral administration\u003cbr\u003e- Storage Conditions: Store in a cool, dry place away from direct sunlight; best utilized within 3 years.\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003eResearch on SLU-PP-332 suggests a variety of potential health benefits:\u003c\/p\u003e\n\u003cp\u003e- Enhanced Endurance: Engages the same genetic pathways activated by aerobic exercise, allowing normal-weight subjects in animal studies to run 70% longer and cover 45% farther.\u003cbr\u003e- Weight Management: Stimulates fatty acid oxidation, facilitating weight loss in obese mice, with reductions of 12% in body weight and significantly less fat gain while maintaining the same diet.\u003cbr\u003e- Improved Insulin Sensitivity: Lowers fasting glucose levels and alleviates markers associated with metabolic syndrome.\u003cbr\u003e- Mitochondrial Biogenesis: Promotes an increase in mitochondrial DNA content and cellular respiration, enhancing overall metabolic efficiency.\u003cbr\u003e- Potential Therapeutic Applications: Under investigation for its efficacy in treating conditions such as Type 2 diabetes, heart failure, and kidney disease. \u003c\/p\u003e\n\u003cp\u003eDosage Information\u003c\/p\u003e\n\u003cp\u003e- Recommended Dose: The typical research dosage for SLU-PP-332 is one to two 1mg capsules daily. Always consult relevant study protocols for specific dosage guidelines.\u003cbr\u003e- Administration Frequency: The frequency of administration will depend on the specific research objectives and individual protocols, usually outlined in the study design.\u003c\/p\u003e\n\u003cp\u003eUsage Protocol\u003c\/p\u003e\n\u003cp\u003e- Administration Method: SLU-PP-332 is intended for oral administration. Capsules should be taken with water for optimal absorption.\u003cbr\u003e- Monitoring Protocol: Participants should be closely observed for response; dosages may be adjusted based on individual tolerance and specific research objectives.\u003c\/p\u003e\n\u003cp\u003eSafety Information\u003c\/p\u003e\n\u003cp\u003e- Side Effects: Preliminary studies report minimal side effects; comprehensive research is needed to determine the complete safety profile.\u003cbr\u003e- Contraindications: Not recommended for individuals with known allergies to ingredients in this formulation.\u003cbr\u003e- Health Warnings: Prior consultation with a healthcare professional is advised before initiating any new research compounds.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing SLU-PP-332, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical standards, and customs requirements. Liability for misuse is expressly disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699153334561,"sku":null,"price":110.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/slu-pp-3321mgcap.jpg?v=1779003886"},{"product_id":"bam15-fat-burner-and-calarie-catalyst","title":"BAM15 Fat Burner and Calarie Catalyst","description":"\u003cp\u003eBAM15 20mg Capsules\u003c\/p\u003e\n\u003cp\u003eBAM15 is a revolutionary research-grade compound designed to enhance metabolic function and promote weight management. It offers a promising avenue for scientific exploration into the mechanisms of mitochondrial uncoupling and energy expenditure. Each capsule provides a precise dosage of 20 mg, facilitating controlled administration for research applications.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Research-Grade Compound: Over 99% purity, verified through third-party laboratory testing.\u003cbr\u003e- Accurate Dosing: Each capsule contains 20 mg of BAM15, ensuring precise administration for various research protocols.\u003cbr\u003e- Convenient Form: Supplied in capsule form, providing ease of use and dosing.\u003cbr\u003e- Formulation: Designed specifically for laboratory and preclinical research applications.\u003cbr\u003e- Packaging: Available in bottles containing 60 capsules each.\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: BAM15 20mg Capsules\u003cbr\u003e- Category: Research chemical for metabolic enhancement\u003cbr\u003e- Supplied In: Bottled capsules (60 capsules per bottle)\u003cbr\u003e- Administration: Oral administration\u003cbr\u003e- Storage Conditions: Store in a cool, dry place away from direct sunlight; best used within two years of purchase.\u003c\/p\u003e\n\u003cp\u003eMechanism of Action (Research Summary)\u003c\/p\u003e\n\u003cp\u003eBAM15 is being investigated for its potential effects on metabolism, with research highlighting several key mechanisms:\u003c\/p\u003e\n\u003cp\u003e- Mitochondrial Uncoupling: BAM15 promotes mitochondrial uncoupling, leading to increased energy expenditure and enhanced fat oxidation.\u003cbr\u003e- Weight Management Support: By potentially raising metabolic rate and promoting fat loss, BAM15 may serve as an effective aid in weight management strategies.\u003cbr\u003e- Improved Glucose Tolerance: Preliminary studies suggest that BAM15 may enhance glucose metabolism, contributing to better insulin sensitivity.\u003cbr\u003e- Exercise Performance: Research indicates that this compound may improve exercise endurance and performance by optimizing energy utilization.\u003c\/p\u003e\n\u003cp\u003eDosage Information\u003c\/p\u003e\n\u003cp\u003e- Recommended Dose: The typical research dosage for BAM15 is one capsules (20 mg) daily. Always consult relevant study protocols for specific dosage guidelines.\u003cbr\u003e- Administration Frequency: The frequency of administration may vary based on individual research objectives and specific protocols as outlined in the study design.\u003c\/p\u003e\n\u003cp\u003eUsage Protocol\u003c\/p\u003e\n\u003cp\u003e- Administration Method: BAM15 is intended for oral administration. Capsules should be taken with water for optimal absorption.\u003cbr\u003e- Monitoring Protocol: Participants should be closely monitored for any physiological responses; dosages should be adjusted as needed based on individual tolerance and specific research objectives.\u003c\/p\u003e\n\u003cp\u003eSafety Information\u003c\/p\u003e\n\u003cp\u003e- Side Effects: Minimal side effects have been reported in preliminary studies. Comprehensive research is required to ascertain the full safety profile.\u003cbr\u003e- Contraindications: Not recommended for individuals with known allergies to any ingredients in the formulation.\u003cbr\u003e- Health Warnings: Consultation with a healthcare professional is advised before initiating any new research compounds.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing BAM15, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical standards, and customs requirements. Liability for misuse is expressly disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699217002785,"sku":null,"price":80.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/bam1520mgcap.jpg?v=1779007181"},{"product_id":"na-epithalon-nh2-telomerase-boost-and-agedefy","title":"NA-Epithalon-NH2 Telomerase Boost and AgeDefy","description":"\u003cp\u003eNA-Epithalon-NH2 10mg\u003c\/p\u003e\n\u003cp\u003eNA-Epithalon-NH2 (N-Acetyl Epithalon Amidate) is a modified, highly stable, and bioavailable version of the synthetic tetrapeptide Epitalon. Designed to act on the pineal gland, this peptide promotes telomerase activity, extends cellular lifespan, and regulates circadian rhythms. Note: The following information is for research purposes based on studies available as of May 2026.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Highly stable and bioavailable synthetic peptide (99+% purity, third-party tested)\u003cbr\u003e- Modified for enhanced resistance to enzymatic degradation compared to standard Epitalon\u003cbr\u003e- Promotes telomerase activity and regulates circadian rhythms\u003cbr\u003e- Supplied lyophilized for investigator-controlled reconstitution and dosing\u003cbr\u003e- Available format: 10 mg total (10 mg NA-Epithalon-NH2)\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: NA-Epithalon-NH2 10mg (Purity: \u0026gt;99+% HPLC)\u003cbr\u003e- Category: Anti-aging and neuroprotective peptide (research chemical)\u003cbr\u003e- Supplied in: Lyophilized powder in sterile vial + 3ml bac water\u003cbr\u003e- Administration (research\/preclinical): Subcutaneous (SQ) injection preferred\u003cbr\u003e- Storage (reconstituted): Refrigerate at 2°C–8°C (39°F); use within 30 days; avoid freeze-thaw cycles\u003c\/p\u003e\n\u003cp\u003ePotential Benefits of NA-Epithalon-NH2\u003c\/p\u003e\n\u003cp\u003e1. Telomere Extension \u0026amp; Cellular Aging: Stimulates telomerase, allowing cells to divide beyond their normal limit, effectively slowing cellular senescence.\u003cbr\u003e  \u003cbr\u003e2. Melatonin Regulation \u0026amp; Sleep Improvement: Boosts melatonin production by the pineal gland, enhancing sleep quality and restoring natural circadian rhythms.\u003c\/p\u003e\n\u003cp\u003e3. Anti-Aging \u0026amp; Antioxidant Effects: Reduces intracellular reactive oxygen species (ROS) and mitigates oxidative stress.\u003c\/p\u003e\n\u003cp\u003e4. Immune System Support: Restores and balances immune function, particularly by increasing T-cell maturation and interleukin-2 synthesis.\u003c\/p\u003e\n\u003cp\u003e5. Neuroprotection \u0026amp; Cognitive Function: Supports brain health, reduces neuroinflammation, and increases amyloid precursor protein metabolism, potentially protecting against cognitive decline.\u003c\/p\u003e\n\u003cp\u003e6. Skin Regeneration: Studies suggest NA-Epithalon-NH2 increases fibroblast proliferation by up to 45%, improving skin collagen and elastin production.\u003c\/p\u003e\n\u003cp\u003eReconstitution and Dosage Guide\u003c\/p\u003e\n\u003cp\u003e• Draw 1.0 mL of bacteriostatic water using a sterile syringe.\u003cbr\u003e• Inject slowly along the vial wall.\u003cbr\u003e• Gently swirl or roll until fully dissolved (do not shake).\u003cbr\u003e• Label and store refrigerated at 2–8 °C, protected from light.\u003c\/p\u003e\n\u003cp\u003eThis results in a concentration of 10mg\/ml (assuming a 10mg vial reconstituted with 1ml BAC water).\u003c\/p\u003e\n\u003cp\u003eRoute \u0026amp; Frequency: Administer once daily via the subcutaneous route, reflecting the cadence commonly used in preclinical models (previously intraperitoneal or local injection). Technique recommendations follow established immunization best-practice guidance.\u003cbr\u003e  \u003cbr\u003eDosing Guide:\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe recommended protocol is 10 mg (10,000 mcg) per night for 10 consecutive nights, followed by a 4-month break before starting another cycle.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eSafety Information\u003c\/p\u003e\n\u003cp\u003e- Side Effects: Minimal in studies, but potential for immunogenicity (immune response to foreign peptide).\u003cbr\u003e- Contraindications: Not for pregnant or breastfeeding women.\u003cbr\u003e- Cancer Disclaimer: Individuals with active or suspected cancer should avoid use, as telomerase activation can theoretically support cancer cell division.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical standards, and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52699260322081,"sku":null,"price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/na-epithalon-nh210.jpg?v=1779007889"},{"product_id":"ghrp-6-the-youth-catalyst","title":"GHRP-6 The Youth Catalyst","description":"\u003cp\u003eGHRP-6 10mg\u003c\/p\u003e\n\u003cp\u003eGHRP-6 (Growth Hormone Releasing Peptide-6) is a potent synthetic hexapeptide that stimulates the release of growth hormone (GH) from the pituitary gland. Known for its ability to promote muscle growth, fat loss, and recovery, GHRP-6 is supplied as a lyophilized powder for investigator-controlled reconstitution. This peptide is widely used in research contexts to explore its potential benefits in performance enhancement and metabolic health.\u003c\/p\u003e\n\u003cp\u003eKey Features\u003c\/p\u003e\n\u003cp\u003e- Stimulates natural growth hormone release\u003cbr\u003e- Promotes muscle growth and fat loss\u003cbr\u003e- Supports recovery and healing processes\u003cbr\u003e- Supplied lyophilized for custom reconstitution and dosing\u003cbr\u003e- Available vial size: 10 mg\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003e- Product Name: GHRP-6 10 mg (Purity: \u0026gt;99% HPLC)\u003cbr\u003e- Category: Growth hormone secretagogue  \u003cbr\u003e- Supplied in: Lyophilized powder in sterile vial + 3ml bac water \u003cbr\u003e- Administration: Subcutaneous injection (typical)  \u003cbr\u003e- Storage (reconstituted): Store at 2–8 °C\u003c\/p\u003e\n\u003cp\u003ePotential Research Applications\u003c\/p\u003e\n\u003cp\u003e- Studies on muscle growth and recovery enhancement\u003cbr\u003e- Investigations into fat loss and metabolic improvements\u003cbr\u003e- Research on the effects of GH release on aging and health\u003cbr\u003e- Combination studies with other growth hormone secretagogues\u003c\/p\u003e\n\u003cp\u003eReconstitution \u0026amp; Dosing Guide\u003c\/p\u003e\n\u003cp\u003eImportant: The following examples are for laboratory reference only. Validate all calculations, aseptic technique, and solvent compatibility with your institutional protocols before use.\u003c\/p\u003e\n\u003cp\u003eExample Reconstitution (10 mg vial + 3 mL sterile water)  \u003cbr\u003e- Resulting concentration: 3.33 mg\/mL  \u003cbr\u003e- Example dosing volumes (U-100 insulin syringe reference):\u003cbr\u003e  - 100 mcg = 0.03 mL (3 units)  \u003cbr\u003e  - 200 mcg = 0.06 mL (6 units)  \u003cbr\u003e  - 300 mcg = 0.09 mL (9 units)  \u003cbr\u003e  - 500 mcg = 0.15 mL (15 units)  \u003cbr\u003e  - 1000 mcg (1 mg) = 0.30 mL (30 units)  \u003c\/p\u003e\n\u003cp\u003eSuggested Research Protocol  \u003cbr\u003e- Typical investigational dose range reported in experimental contexts: 100–300 mcg per administration  \u003cbr\u003e- Common schedule used in research: 1-3 times daily to maximize GH secretion  \u003cbr\u003e- Cycle lengths in study designs: 4–12 weeks on with 4 weeks off; tapering generally not required  \u003cbr\u003e- Protocols should be designed and approved by qualified investigators and institutional oversight\u003c\/p\u003e\n\u003cp\u003eResearch Insights\u003c\/p\u003e\n\u003cp\u003eGHRP-6 has shown significant promise in stimulating endogenous growth hormone release, leading to increased muscle mass and enhanced recovery. Its potential benefits in fat loss and metabolic regulation make it a valuable subject for ongoing research in exercise physiology and metabolic health.\u003c\/p\u003e\n\u003cp\u003ePossible Observations and Adverse Events (Preclinical\/Experimental Context)\u003c\/p\u003e\n\u003cp\u003e- Mild local irritation at the injection site  \u003cbr\u003e- Temporary increase in hunger or water retention\u003c\/p\u003e\n\u003cp\u003eStorage, Stability, and Handling After Reconstitution\u003c\/p\u003e\n\u003cp\u003e- Reconstituted solutions: store at 2–8 °C and protect from prolonged light exposure. Use within 30 days for optimal efficacy.\u003c\/p\u003e\n\u003cp\u003eSafety and Handling\u003c\/p\u003e\n\u003cp\u003e- Follow institutional biosafety, handling, and waste disposal protocols. Ensure compliance with local laws and regulations.\u003c\/p\u003e\n\u003cp\u003eFrequently Asked Questions\u003c\/p\u003e\n\u003cp\u003eQ: Is 100 mcg a reasonable starting research dose?  \u003cbr\u003eA: Many protocols begin conservatively at 100–200 mcg; dose selection should align with study objectives and institutional approvals.\u003c\/p\u003e\n\u003cp\u003eQ: Can GHRP-6 be dosed multiple times daily?  \u003cbr\u003eA: Yes — it is commonly administered 1-3 times daily, with dosing schedules tailored to research needs.\u003c\/p\u003e\n\u003cp\u003eQ: When might effects be observed?  \u003cbr\u003eA: Benefits in muscle growth and recovery may be noticeable within a few weeks, depending on individual responses and concurrent interventions.\u003c\/p\u003e\n\u003cp\u003eLegal and Regulatory Notice\u003c\/p\u003e\n\u003cp\u003eBy purchasing this product, you confirm that you are acquiring it for lawful research purposes. It is the purchaser’s responsibility to ensure compliance with local laws, institutional policies, ethical, and customs requirements. Liability for misuse is disclaimed.\u003c\/p\u003e","brand":"moonspellsbeauty","offers":[{"title":"Default Title","offer_id":52736744948001,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/files\/GHRP610_9aa5168a-ad5f-4ec0-8718-7a08eb39b614.jpg?v=1779269467"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0795\/0601\/4497\/collections\/peptide_therapy.jpg?v=1775190245","url":"https:\/\/moonspellsbeauty.com\/collections\/peptide-therapy.oembed","provider":"Moonspells Beauty","version":"1.0","type":"link"}